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ABSTRACT
It is an offence to drive a car whilst impaired due to use of a psychoactive 
substance. The incidence of illegal drug use has escalated in recent years, and 
this escalation is also represented in the driving population. At present there is 
no objective tool which can be used at the roadside to assess the drug induced 
performance impairment of drivers suspected of illegal drug intoxication. A 
literature analysis highlighted that empirical investigation into the cognitive and 
psychomotor effects of illegal drug use on aspects of performance related to car 
driving was scarce. By drawing together empirical and epidemiological evidence 
it is possible to conclude that driver impairment, as a consequence of illegal drug 
use poses a significant threat to traffic safety.
Psychopharmacology is based on the premise that drugs affect behaviour, and 
that this change in behaviour is measurable. Behaviour is assessed through the 
use of repeated psychometric assessment in the laboratory. The aim of this 
thesis was to demonstrate that by using a portable device it was possible to 
reliably assess drug induced performance impairment in field conditions, with 
just one set of assessments.
The portable psychometric test battery was demonstrated to be a valid tool in 
discerning the performance decrement induced by an impairing dose of alcohol. 
The test battery also proved efficacious in assessing the cognitive and 
psychomotor performance of drugged subjects in field conditions. Using 
statistical modelling it was demonstrated that it was possible to make 
retrospective judgments regarding an individual’s drug use based solely on their 
performance on the psychometric test battery.
The field impairment test is a subjective assessment tool in which police officers 
assess a suspect’s performance on certain physical tasks. Based on 
performance officers are required to make personal judgments regarding the 
individual’s impairment. The portable psychometric battery was shown to be 
more reliable than the subjective measure currently endorsed by the Police 
Force.
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CHAPTER 1
GENERAL INTRODUCTION AND LITERATURE ANALYSIS
1.1 The Effect of Illicit Drug Use on Driving Ability
Driving a car is a complex multifaceted psychomotor and perceptual task 
involving vigilance, information processing under variable demand, sensory 
motor control, divided and sustained attention, perception, and cognitive 
functioning (DelRio and Alverez, 2001; Moskowitz and Robinson, 1988; Ogden 
and Moskowitz, 2004; Ranney, 1994; Roth et al., 1992). Driving is performed in 
a dynamic environment, where critical situations develop quickly and 
unexpectedly. Drivers are required to react in a matter of seconds, co-ordinate 
motor movements, process information, make decisions, and remain attentive. 
However, driving performance has been shown to quickly deteriorate as a direct 
consequence of the use of psychoactive drugs (O'Hanlon, 1984; Ramaekers, 
2003; Verster and Volkerts, 2004a, b; Verster et al., 2002). The prevalence of 
illegal psychoactive drug use within society has increased dramatically in recent 
decades (Aust et al., 2002) consequently a growing number of this drug using 
population is likely to drive (Oliver, 2004). Since the 1990’s the relationship 
between illegal drug use and driving has been subject to growing investigation 
and concern (Kelly et al,. 2004; Logan and Couper, 2001; Ogden and Moskowitz 
2004; Toennes et al., 2005). The belief is that consumption of illegal drugs pose 
a considerable degree of risk to road traffic safety (Albery et al., 1998; DelRio, 
1995r Kruger et al., 1995), and that driving whilst under the influence (DWUI) of 
drugs other than alcohol is an increasing cause of accident fatalities (Morland, 
2000; Movig et al., 2004; Seymour and Oliver, 1999).
The IMMORTAL project (Impaired Motorists, Methods of Roadside Testing and 
Assessment for Licensing) was a 36 month long innovative research project led 
by a European consortium that started in January 2002 comprising of ten 
partners. IMMORTAL had three main scientific objectives: to investigate the 
influence of chronic and acute impairment factors on driving performance and 
accident risk; to recommend criteria and/or tolerance levels for categories of 
impairment; and lastly to provide information to support the formulation of 
European policy. This spawned a wealth of empirical and epidemiological data. 
The main conclusions and recommendations of the project expressed a need for 
the development of an objective device that could be used at the roadside to 
assess drug induced driver impairment. The ROSITA project (Roadside Testing 
Assessment) was also specifically created to address the Europe wide drink and 
drugged driving problem (Verstraete and Puddu, 2000). The objectives of 
ROSITA were to identify the requirements for roadside impairment testing 
equipment addressing aspects such as validity, reliability and usability. Both of 
these European wide initiatives identified a need for the development of a 
psychometric tool with which impairment could be measured and quantified.
In 2000, 1800 people in the UK were convicted of drugged driving (Potter, 2002). 
In most European countries, legislation on drugs and driving is covered by 
general regulations on impaired driving. However, as no standardised criteria or 
definition of impairment is in place, it is not easy to prove driver impairment. Due 
to this difficulty, some countries have introduced a “per se” law pertaining that it 
is an offence to drive if any trace of an illegal substance can be detected in the 
blood of the driver. Just such a law has been effective in Germany since 1998 
and in Sweden since 1999. In the UK, the law directs that it is an offence for any 
person to be in charge of a motorised vehicle whilst “unfit” (Sections 3a and 4 of
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the Road Traffic Act 1988). Unfit is subsequently defined as “impaired”, however 
“impaired” is defined nowhere in the Act. How impairment is to be established at 
the roadside is open to considerable debate. There is a well-established legal 
framework for prosecuting drivers found to be in excess of the legal alcohol limit 
however, the UK does not have such a “per se” law, regarding drug use. The 
introduction of legislation to allow for roadside drug screening in saliva would not 
prove impairment, but rather that the driver had drugs on board. The 
controversy therefore remains as to how impairment at the roadside can be 
objectively assessed. Many UK police forces currently use the Field Impairment 
Test (FIT) at the roadside to assess whether a driver who obtains a negative 
result in a breathalyser is fit to drive. The FIT test has been heavily criticised 
(O'Keefe, 2001) as it is a highly subjective assessment tool characterised by the 
suspect being requested to carry out various physical tasks which have been 
designed to assess psychomotor functioning. The problem arises in that there 
are no pass or fail criteria, nor guidelines on how to rate the individual's 
behaviour, yet the driver can be arrested based on their performance (Collier, 
2001). In 2002 a need was identified by the IMMORTAL and ROSITA projects 
for an objective method of determining impairment due to a psychoactive 
compound, which could be reliably used at the roadside. The empirical use of 
psychometric assessment to determine impairment is well established.
1.2 Summary of the Driver Behaviour Models
In order to understand fully the key aspects of driver behaviour, and how these 
behaviours can be quantitatively assessed it is important to summarise 
theoretical models of driving behaviour. Since the 1960’s several driver 
behaviour models have been proposed, however these theoretical accounts of
driving behaviour have not yet reached a consensus (Ranney, 1994). Three 
divergent models currently exist: taxonomic, functional and driver error models.
Taxonomic models address the relationship between individual differences, and 
the prediction of accident involvement (Elander et al., 1993; Lester, 1991; 
Hilakivi et al., 1989), but do not account for any underlying psychological 
processes that may have given rise to the accidents. This makes extrapolation 
of results to facilitate improvement to driving safety difficult (Michon, 1985). It is 
for this reason that functional models of driving behaviour are prevalent. 
Functional models of driving behaviour include motivational (Naatanen and 
Summala, 1974; Wilde, 1982; Fuller, 1984; Molen and Botticher, 1988) and 
information processing theories (Michon, 1985; Rasmussen, 1987). Information 
processing theories of driver behaviour attempt to provide a functional, testable 
explanation of the driving task (Michon, 1985), with the driver seen as a passive 
responder to incoming stimuli. Conversely, motivational theories are concerned 
with the level of risk drivers are willing to accept, the driver is seen as an active 
decision maker carrying out safety analyses (Gibson, 1966). The proponents of 
driver error models argue that an individual’s information processing capability is 
subject to a limited capacity, and it is this limitation that leads to diver error, and 
involvement in traffic accidents (Brehmer, 1990).
In a staunch criticism of the driver behaviour models Michon (1985), stated that 
the lack of emphasis on cognitive processing when theorising about driver 
behaviour has contributed to the lack of progression within the field. He argued 
that there are distinct hierarchical cognitive control structures that govern driving 
behaviour, and that there is a systematic interaction between the driver and their 
environment. This systematic interaction can be divided into three levels of skill
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and control. A strategical level, a maneuvering level, and a control level 
(Michon, 1971; 1979; Janssen, 1979). A diagram of the hierarchical structure is 
presented in Figure 1.1. The strategical level determines the planning stage of a 
journey, including aspects such as the purpose of the journey, the route taken 
and an assessment of the cost, benefits and risks involved. At the maneuvering 
level, drivers employ tactical control enabling them to carry out tasks such as 
gap estimation, turning, overtaking and avoiding obstacles. These maneuvers 
are carried out in order to meet the goals set at the strategical level. The control 
level governs automatic action patterns, which also allows for the flow of 
information from one level in the hierarchical structure to another. It has been 
argued that this level operates outside of conscious control (Smiley, 1986), 
requiring fast and effortless processing and it is for this reason that skills carried 
out at this level are more susceptible to the disruption caused by psychoactive 
compounds. (Lamers and Ramaekers, 2001).
Figure 1.1 The hierarchical structure of the driving task.
Environmental
Innut
Environmental
Innut
Control Level
Strategical Level
Manoeuvring Level
-► General Plans
-► Controlled Action 
Plans
-► Automatic Action 
Plans
This figure represents diagrammaticaily the hierarchy of skills employed during the driving task. Driving 
performance is said to be a dynamic activity organised across these three levels (Michon 1985).
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In 2004, Ramaekers attempted to put this theory of hierarchical structure into 
context to facilitate the empirical assessment of driver impairment. He argued 
that tests such as Standard Deviation of Lateral Position (SDLP), and car 
following tests assess driving at the manoeuvring level, and that psychometric 
test batteries, and road tracking tasks assess driver behaviour at the control 
level (Ramaekers, 2004). The control level is seen as an important level to 
assess empirically as it is at this level, that skills involved in the driving task can 
be broken down and investigated in detail.
1.3 Empirical Methodologies for Assessing Driver Impairment
Various methodologies have been developed to assess driver performance. 
Performance can be defined as the plethora of skills and behaviour 
characteristics that are required in everyday life (Roth et al., 1992). The 
assessment of impairment therefore focuses on these well practised skills of 
cognitive and psychomotor functioning, and it is assessment of these skills which 
draws the focus of empirical research. Roth et al., (1992) characterised the 
various methods of assessment into two categories: applied and analytical. 
Applied methods simulate aspects of the driving task, such as on the road 
assessments, simulators and gymkhana tests, assessing driving behaviour at 
the strategical and manoeuvring level. Analytical techniques assess the 
individual components necessary for task completion using standardised 
laboratory testing (Broadbent, 1984), incorporating aspects of driving relating to 
the control level.
1.3.1 Applied Methods
1.3.1.1 Standard Deviation of Lateral Position (SDLP)
Developed in the 1980's the SDLP is a standardised driving test used to assess 
a subjects steering ability in real life, on the road (O'Hanlon, 1984; O'Hanlon et 
al., 1982). In a standardised version of SDLP subjects drive an instrumented 
dual control vehicle over a 100km circuit of highway in normal traffic conditions. 
They are instructed to maintain a constant speed (approximately 58mph) and a 
steady lateral position. Lateral position is measured via an electro-optical lane 
tracker and speed is determined by the revolutions of the tyres. A licensed 
driver accompanies the subject, in order to terminate the test if the subject’s 
driving becomes unsafe. The amount of weaving of the car is the primary 
response measure, known as Standard Deviation of Lateral Position (SDLP). 
SDLP is said to represent the amount of vehicle control a subject has (Volkerts 
and VanLaar, 1995). Data from several studies has led to SDLP being accepted 
as an efficacious measure of driving safety (O'Hanlon, 1984; O'Hanlon et al., 
1982), and sensitive to the effects of drug induced impairment (Burns and 
Moskowitz, 1980; O'Hanlon et al., 1998; O'Hanlon et al., 1995; O'Hanlon and 
Volkerts, 1986; Ramaekers et al., 1992; Sexton et al., 2000; VanLaar et al., 
2001; Verster, 2002; Volkerts and VanLaar, 1992). This test has also been 
shown to correlate with standardised laboratory methods of assessment, i.e. 
psychometric test batteries (Patat, 1998). However, SDLP has been criticised 
for being a test which measures skills unrelated to real world driving, 
consequently calling into question the value of the applied results (Willumeit et 
al., 1993). It was argued that SDLP requires a low vigilance level from the 
subject, which is converse to the real world driving environment which requires a 
combination of high and low vigilance levels.
1.3.1.2 Car Following
Similarly to SDLP, car following tasks involve real driving situations. Subjects 
are instructed to follow a test car at a “safe” distance in “heavy” traffic. Subject’s 
performance is assessed through a combination of three response measures: 
choice of speed, use of the vehicle controls, and the degree of intervehicle 
separation. Some studies have used a test car equipped with laser devices 
capable of measuring intervehicle distance to an accuracy of 0.1m (Lamble et 
al., 1999). Other studies however have used different methods of data 
collection, such as deviation of lateral position and assessment of the subject’s 
reaction to the speed changes of the lead car (Brookhuis and De Waard, 1993). 
Extrapolation of the results is therefore problematic. Those who favour car 
following tasks argue that speed control requires a high level of perceptual-motor 
control, as the subject is estimating time to collision, an essential facet of safe 
driving (Lamble et al., 1999).
SDLP and Car Following test methods are favoured due to assessment being 
carried out in normal traffic conditions. This is thought to provide a high degree 
of face and ecological validity, which cannot be replicated in driving simulators or 
in the laboratory. However, conducting driving assessment in this manner is 
extensively time consuming and expensive, irrespective of the safety 
implications to the subjects and other road users. An important issue that 
cannot be ignored is that in the study of drug induced driver impairment, true 
measurements of the detrimental effect a drug is having on an individual’s ability 
to drive is essential. Standard practice in both the SDLP and car following task 
is that the trials are terminated if the subjects’ performance deteriorates below a
certain level, thus critical information as to the serious adverse effects a drug 
has on cognitive and psychomotor skills are excluded from analysis. These 
important issues have contributed to the development of further comparable 
means of assessing driver performance, such as driving simulators, analogues 
of driving, and test batteries.
1.3.1.3 Driving Simulators and Driving Analogues
Driving simulators and laboratory based driving analogues allow impairment to 
be assessed within a safe environment comparable to the environment of a real 
road. Modern simulators project driving landscapes and subjects are assessed 
on various tasks such as hazard perception, speed control, and risk taking 
(Burian et al., 2002). Driving analogues carried out in the laboratory include for 
example, the assessment of night time driving where subjects are presented with 
a series of horizontal light movements in the dark, in order to replicate the 
stimulus provided on the road when driving at night (Hindmarch, 1983).
Although simulators and driving analogues offer a more controlled environment 
which is necessary for scientific investigation, they prove highly expensive and 
as time consuming as the on the road tests. Studies suggest they are not 
sufficiently sensitive to the effects of drug induced impairment (Volkerts et al., 
1992), and where significant effects are reported, it is only at the acute doses 
(Brookhuis et al., 1990; ludice et al., 2002; Willumeit et al., 1984). Further, 
where significance has been reported, testing methods and results are so 
disparate that comparison, or extrapolation is difficult (Bocca et al., 1999; 
DeWaard et al., 2000; Mattila et al., 1998). Another analogue of driving which 
has been shown to be sensitive to drug effects (Hindmarch et al. 1983), and still
offer the driving stimulus of a real life car on the road is the brake reaction time 
driving analogue (BRT).
BRT assesses a subject’s reaction time to a light stimulus whilst maintaining a 
constant driving speed of 30mph on a private driving track that is closed to other 
traffic. The stimulus takes the form of a red light mounted on the bonnet of the 
test car, the intention being to mimic the brake light of an imaginary car in front 
of the test vehicle (Hindmarch et al., 1983). The light is illuminated at random 
intervals throughout the test with the subject required to extinguish the light by 
depressing the brake pedal as quickly as possible. Each test contains 25 
randomly occurring trials, presentations of which are controlled by a computer. 
The main response variable is the mean reaction time. The test cars are dual 
controlled to allow a tester to accompany the subject to maintain safety. Testing 
on a private closed circuit particularly lends itself to the investigation of drug 
induced driver impairment as it allows for testing to continue beyond a point at 
which testing on a public road would have to be terminated. BRT has been 
shown to measure the effects of a range of psychoactive compounds 
(Hindmarch and Subhan, 1983; Hindmarch et al., 1983; Ridout and Hindmarch, 
2001), and a positive correlation has been demonstrated between reaction time 
and accident frequency (Willumeit et al., 1993).
It is clear that although all of these tests have proven efficacious for assessing 
driver impairment in scientific conditions none of them would lend themselves to 
use at the roadside. Although objective, they are not portable, i.e. could not be 
carried around by officers, and are not cost effective. These tests are also 
complicated to carry out and interpret unless the user is skilled in the area of
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behaviour assessment. Analytical methods would offer a more sensible 
alternative.
1.3.2 Analytical Methods
Psychometric tests are typically carried out in the laboratory under strictly 
controlled conditions. This produces an alien environment for the subject in 
which they are not responsible for maintaining their own safety, or the safety of 
others. However, the use of psychometrics allows for a sensitive, qualitative, 
comprehensive, replicable and standardised assessment of the disruption of 
discrete cognitive and psychomotor processes (Wetherell, 1996) and there is a 
large body of evidence detailing the reliability, validity and standardisation of 
measuring the psychomotor effects of CNS active drugs through the use of 
psychometry (Parrott, 1991a, 1991b, 1991c).
Parrott’s series of three papers (1991a, 1991b, 1991c) attempted to bring issues 
of standardisation, reliability and validity into focus. Parrot put forward a set of 
recommendations that he believed would lead to a higher degree of 
standardisation within the discipline of human performance research. He 
particularly highlighted the necessity for test documentation. Although he 
acknowledged that it would be misguided to attempt to write a restrictive list, this 
test documentation would allow for the quality of the tests to be assessed 
(Parrott, 1991a). In terms of reliability, the author believed that test-retest 
reliability was the single most important summary measure to report to the wider 
community when a test is in development, Test-retest reliability assess the 
variance in scores between test sessions, the belief being that a test with high 
reliability would produce similar scores on different occasions (Anastasi, 1982). 
Parrots work on validity covered four main facets: content, criterion, construct
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and face validity. Content validity is an estimate of the appropriateness of the 
tests selected based on a detailed examination of the content of the test items. 
Criterion validity concerns itself with the correlation between the psychometric 
tests and the actual behaviour that the tests are attempting to assess. Parrott 
believed construct validity to be the most accurate representation of traditional 
methods within psychology, being mostly concerned with aspects of test 
meaning and interpretation (Parrott, 1991c). Face validity is highly subjective in 
nature, and is an assessment of whether the test looks like it is measuring what 
it is meant to be. Although this method of assessing validity could be 
misleading, it does have certain advantages. For example, subjects would be 
more motivated to complete psychometrics that they believed bore some 
relevance to the real life task that is meant to be being assessed.
There is a vast array of psychometric tests used to assess the cognitive and 
psychomotor effects a drug is exerting on an individual; Information processing 
tasks, memory tasks, cognition tasks, spatial tasks, vigilance tasks, visuo-motor 
tasks and reaction time tasks (Moskowitz and Fiorentino, 2000). In order to 
study different facets of cognitive and psychomotor performance several tests 
are combined into a battery to thoroughly assess the range of effects that a 
psychoactive compound is producing.
In 1988 a review was published by Moskowitz and Robinson detailing the effects 
of low doses of alcohol on driving related behaviour (Moskowitz and Robinson, 
1988). They demonstrated that the tests commonly used to assess driving 
related skills were; performance in simulators and on the road driving 
assessments, reaction time, tracking, divided and sustained attention, 
information processing, visual functioning, and perceptual and psychomotor
-12-
tasks. The psychometric assessments which showed the greatest sensitivity 
were the attention, vigilance and tracking tasks. Tracking tasks are interactive 
tasks that require the subject to track a moving object by means of a mouse or 
joystick. More complex tracking tasks include a divided attention and reaction 
time component, where the subjects are required to continue with the tracking 
task whilst simultaneously attending to a secondary task. Complex tracking 
tasks are thought to be good models of the perceptual cognitive demands placed 
on an individual during complex situations such as driving (Moskowitz, 1984). 
Other literature has shown tracking tasks and reaction time tasks to be the most 
sensitive and reliable tests related to driving ability (Ogden and Moskowitz, 
2004; Patat 1998).
Errors of attentional efficiency and information processing have also become 
one of the most frequently cited contributors to the increased likelihood of 
involvement in road traffic accidents (Riedel et al., 1998b). It has been well 
documented that the strongest and most consistent predictor of accident 
involvement is selective attention (Avolio et al., 1985; Barrett and Thornton, 
1968; Kahneman et al., 1973; Mihal and Barrett, 1976). Selective attention is the 
process involved in situations when an individual is confronted with multiple 
stimuli, and must select one aspect to attend to. Impaired subjects may choose 
to concentrate on one task at the expense of another (Roth et al., 1992).
Applied and analytical methods of assessment offer numerous methods of driver 
assessment with positives and negatives intrinsic to each. Due to the 
inappropriateness of the applied assessments to be utilised for roadside 
screening the question is whether a psychometric test battery on a durable and 
portable device, would offer a realistic option for roadside testing. Such a
-13-
psychometric battery would have to be able to provide meaningful results after 
an individual's first exposure to it, a challenge for the field as traditionally 
psychometry specialises in the comparison of performance to an unimpaired 
baseline. This information simply would not be available at the roadside. The 
considerable advantage of a psychometric test system over other testing 
methods is that it would provide a standardised, quantitative and objective 
method of assessment quite contrary to what is in use at the moment; the Field 
Impairment Test: a subjective method of assessment.
1.3.3 Subjective Methods of Assessing Driving Ability
Drug Recognition and Field Impairment Testing (FIT) was implemented into 
officer training in the UK in 2000 (Collier, 2001). It is derived from the 
Standardised Field Sobriety Test (SFST) which has been in use since 1979 in 
the USA (Burns and Moskowitz, 1977). The FIT is used at the roadside to 
assess impairment in a driver who has passed a breathalyser but is suspected of 
driving under the influence of an impairing substance. The FIT is used as a 
screening technique to allow officers to assess an individual’s level of 
impairment, and whether the individual should be taken to the police station for 
further evidential investigation. The FIT is unique in the fact that rather than 
being an objective laboratory test, it is highly subjective in nature. There are no 
pass or fail criteria. Each trained officer is required to assess performance in 
terms of "clues" or "indicators" for each test. A final value judgement is made as 
to the individual’s level of impairment.
Thos who support application of the FIT argue that it assesses the cognitive and 
psychomotor status of an individual, and crucially, it requires an individual to
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divide their attention (Collier, 2001). Individuals are assessed on their ability to 
follow instructions and perform multiple tasks simultaneously. The FIT consists 
of a pupillary assessment, where officers measure the size of the individual’s 
pupils and four additional tests. The tests are: the Romberg test, where 
individuals are required to estimate the elapse of thirty seconds; the Walk and 
Turn Test, in which individuals are required to walk along an imaginary straight 
line in an identical manner to that which they have been shown by the officer. 
The One Leg Stand requires the subject to balance on first one foot and then the 
other whilst counting out aloud. The last test, the Finger to Nose Test requires 
the individual to touch the tip of their nose with the tip of their finger whilst their 
eyes are closed (O'Keefe, 2001).
How these tests relate to actual car driving behaviour other than simple motor 
skills remains unclear (Hartley et al., 2004; Johnston and Ramsey, 2003). A 
further criticism levelled at the FIT program is that due to the high degree of 
subjectivity involved in its execution, performance on each component of the test 
is open to misinterpretation (O'Keefe, 2004). However, it has also been 
demonstrated that, in practical terms, officers performing the FIT are capable of 
achieving a 92% success rate, success being defined as the percentage of 
positive evidential samples obtained following the FIT assessment (Tunbridge et 
al., 2002).
1.4 Prevalence and European Epidemiology
Epidemiological investigation provides an awareness of the conditions and 
populations which are at risk from drugged driving. Although only an associative 
not causal link can be established, these studies provide important information in 
terms of the frequency with which the illegal drugs are associated with accidents.
-15-
Due to the similar legal structure of countries across Europe, these 
epidemiological investigations can provide a more global indication concerning 
which drugs represent the highest risk.
Driving under the influence of drugs other than alcohol is considered to be an 
increasing cause of traffic accidents and deaths world-wide (Morland, 2000). 
Statistics clearly demonstrate that illegal drug use and road safety is an 
expanding problem. The Transport Research Laboratory (TRL) conducted two 
studies into the influence of drugs on road accident deaths. Between 1985 and 
1998, illegal drugs were involved in only 3% of road deaths. A decade later, 
results from 1996-2000 showed the figure had grown to 18%, with two thirds of 
these cases involving cannabis (Tunbridge et al., 2001). This increase in 
prevalence can be demonstrated across Europe. In Norway the number of 
drivers suspected of driving whilst under the influence has increased by over 
100% during the 1990’s (Hausken et al., 2004). In 1991, 17 drivers tested 
positive for heroin use, this rose to 320 in 1999. For ecstasy cases in 1995 6 
drivers were apprehended, this rose to 123 drivers in 1999. Poly-drug use was 
also prevalent, in excess of 80% of cases (Hausken et al., 2004).
In the late 1990's four large scale epidemiological investigations were carried out 
(Ferrara et al., 1990; Kruger et al., 1995; Meulemans et al., 1996; Skurtveit et al., 
1995). In the German study (Kruger et al., 1995) a roadside survey was 
conducted over a two year period to determine the prevalence of illegal and legal 
drug use in the general driving population. A total of 3,027 saliva samples were 
analysed for the presence of cannabinoids, amphetamines, opiates, cocaine, 
barbiturates and benzodiazepines. In the Norwegian study (Skurtveit et al., 
1995) a total of 2,819 blood samples of drivers suspected of driving under the
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influence were analysed for the most commonly abused drugs if the BAC of the 
driver was below the Norwegian legal limit. The large scale Italian study (Ferrara 
et al., 1990) focused on the drug use of 5,000 injured road users hospitalised 
over a ten year period. These samples were analysed for over 72 different legal 
and illegal drugs. The Belgian study (Meulemans et al., 1996) focused on 2,143 
hospitalised drivers involved in collisions. These samples were analysed for the 
presence of amphetamines, cannabinoids, cocaine, opiates, methadone, 
benzodiazepines and barbiturates. Although the results from these studies are 
not directly comparable due to variability in study methodologies, and driver 
populations, this data does highlight the high prevalence of illegal drug use in 
road traffic. A summary of the results is presented in Table 1.1.
Table 1.1 The prevalence of illegal drug use in drivers across four 
European countries
General Driver Population DWUI driver population Collision involved 
driver population
Country Germany Norway Italy Belgium
Drug
Cannabis 0.06% 26% 5.5% 6.0%
Opiates 0.7% 8% 3.5% 7.5%
Amphetamines 0.08% 21% 2.7% 3.0%
Cocaine 0.01% 0.04% 0.05% 0.7%
This table summarises data from four European countries representing the prevalence of drug use in 
different samples of the driving population (Ferrara et al., 1990; Kruger et al., 1995; Meulemans et al., 
1996; Skurtveit et al.,1995). The general driver population would have been drivers stopped at random 
and tested. DWUI refers to drivers who were apprehended for Driving Whilst Under the Influence.
The studies also demonstrated that cannabis is the drug detected with the most
frequency, closely followed by the opiates, whether it be in a random sample of
drivers, those DWUI, or those involved in collisions (Ausberger and Rivier, 1997;
Christophersen et al., 1995; Moller, 1994; Moller et al., 1999; Seymour and
Oliver, 1999; Skurtveit et al., 1995; Steentoft et al., 1997). Poly-drug use in the
general drug using population is on the increase. The large scale German
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investigation which studied the general driving population stopped at random 
reported that 30% of the drug positive cases were positive for a combination of 
illegal drug and alcohol use, and that in 95% of cases the samples were positive 
for more than one illegal drug. This high prevalence has also been 
demonstrated in Norway. Of a sample of 425 drivers DWUI but negative for 
alcohol 26% were positive for cannabis. 82% of these positive samples were 
also found to be positive for one or more drugs in addition to cannabis, and the 
concentrations of the secondary drugs were often high (Gjerde and Kinn, 1991).
A more recent large scale Driving Whilst Under the Influence (DWUI) 
investigation was carried out in Scotland (Seymour and Oliver, 1999). 
Approximately 752 biological samples of drivers suspected of DWUI were 
analysed over a nine year period (1992 -  2003). This study clearly 
demonstrated that as drug misuse in Scotland rose, so did the number of DWUI 
cases. Again, poly-drug use was of high prevalence comprising two thirds of the 
sample, as is presented in Figure 1.1. In 1995 poly-drug use was identified in 
approximately 70 cases, this rose to approximately 130 cases in 2002. This 
study also highlighted that the drugs detected with the highest prevalence in 
1995 were benzodiazepines (far in excess of therapeutic doses), and 
cannabinoids followed by opioids. In 2002 a shift had occurred, opioids rose to 
the drug found with the second highest prevalence.
-18-
Figure 1.2 The distribution of poly-drug use identified in drivers in a 
large scale Scottish investigation
4 drugs 5dru9s
2 drugs 
36%
This figure presents the distribution of poly-drug use amongst a sample of 752 drivers apprehended for 
driving whilst under the influence of illegal drugs (Seymour and Oliver, 1999).
Epidemiological evidence whilst being able to provide evidence pertaining 
prevalence of use, such investigations cannot be used to demonstrate a causal 
link between drug use and accident involvement. The evidence gained through 
epidemiological investigation has led authors to conclude that drug use, 
especially alcohol, multiple drug use and drug alcohol combinations increases 
the risk of road traffic accidents (Movig et al., 2004). Review of the empirical 
data also highlights this.
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1.5 Literature Analysis of the Effects of Illegal Drug Use and Driving 
Behaviour
A thorough understanding of the influence of illegal drugs on driving safety can 
only be achieved through a combination of epidemiological and empirical 
investigation (Simpson and Vingilis, 1992). Empirical research focuses on the 
disruption of discreet psychomotor and cognitive abilities that are impaired 
through illegal drug use; however it is often difficult to extrapolate from these 
results to accident causality. Questions such as the extent and magnitude of 
illegal drug involvement in road accidents, and which drugs pose the most 
danger can be answered through epidemiological investigation.
1.5.1 Literature Analysis Methods
The objective of this literature analysis was to determine whether illegal drug 
use impairs driving ability or aspects of behaviour related to driving ability. 
Impairment being defined as the demonstration of a significant decline in 
performance (Ogden and Moskowitz, 2004). Methods of assessment which 
have been deemed to be measuring skills specifically related to driving ability 
have been detailed elsewhere (Moskowitz and Robinson, 1988; Ogden and 
Moskowitz, 2004; Roth et al., 1992), and are summarised in Table 1.2. Not 
all forms of psychometric assessment were included in the review, for 
example, self paced tasks which allow the subjects to control the flow of 
information, instead of it being experimenter led were excluded. It is believed 
that these tasks are less sensitive to the sedative effects of drugs and that as 
the driving situation is not self paced (Roth et al., 1992), results from self 
paced tasks will have little relevance to this review. Table 1.2 details the 
criteria under which papers were included in the literature analysis.
- 2 0 -
Only the abused forms of drug (cannabis, heroin, cocaine, amphetamine, and 
ecstasy) were included as search terms using PubMed, Medline and Science 
Direct. Although it is appreciated that this would limit the availability of 
experimental data it was felt necessary to gain a true picture of the effect of 
illegal drug use on driving ability. Medicinal alternatives could subvert any 
conclusions made surrounding the dangerousness of a drug. For example, 
in the cannabis studies presented here doses range from 100-300pg/kg. 
Ramaekers et al., (2000) states that doses typically preferred by recreational 
cannabis users are around 300pg. Smith et al., (1962) demonstrated 
performance differences between morphine and heroin conditions, and 
advised caution in extrapolating morphine results to heroin abuse situations. 
Many studies were found which prescribed medicinal methamphetamine for 
the treatment of obesity, attention deficit, and narcolepsy. However, Logan 
(1996) believes that clinical trials which use these subject populations 
possess limited advantages when examining the effect of the illegal use of 
the amphetamines, as the doses taken by methamphetamine abusers (up to 
300mg per dose), exceed the doses typically prescribed (up to 60mg).
-21 -
Table 1.2 Literature analysis criteria
Study Design: Placebo controlled or non using matched sample
Population: Healthy volunteers 
Recreational drug users 
Drug addicts/dependents (defined by DSM-IV 
[American Psychiatric Association 1994] criteria)
Intervention: Cannabis
Heroin
Cocaine
Amphetamine
Ecstasy
Poly-drug use (alcohol and multiple drugs)
Methods of
Assessment: Driving tests, simulators and analogues
Motor Performance
Complex Reaction Time
Attention and Vigilance
Information Processing
Psychophysical and physiological processes
English, peer reviewed only, publication date of 1980
Publication type onwards
A table detailing the criteria for a literature analysis looking at the effect that illegal drug use has on 
driving and driving related skills.
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1.5.2 Cannabis
Based on this literature review a pattern of performance impairment did emerge 
from studies that assessed the driving behaviour of subjects that had been given 
the larger doses of THC prior to testing. Robbe (1998), demonstrated this in two 
separate studies. The lower dose of THC produced no impairment whether on a 
highway closed to other traffic, or on the highway in the presence of other traffic. 
The two higher doses of cannabis significantly impaired driving in both the 
highway driving conditions. Papafotiou et al., (2005b) also reported that driving 
was significantly impaired in subjects assessed using a driving simulator. Two 
separate doses of cannabis caused subjects to have impaired control, collide 
with an increased number of obstacles, and display an inability to maintain 
lateral position (Papafotiou et al., 2005b).
In addition to his highway driving investigations, Robbe (1998) conducted a third 
investigation, assessing the effects that the poly-drug use of alcohol and 
cannabis would have on driving performance. Based on results from all three 
studies Robbe concluded that when cannabis was taken alone the degree of 
impairment increased from small to moderate (Robbe, 1998). However, when 
these doses of cannabis were combined with small doses of alcohol driving was 
significantly and severely impaired (Robbe, 1998). In 2000 Ramaekers also 
demonstrated that subjects driving performance was significantly impaired by 
cannabis use. This same study also investigated the effect of the poly-drug use 
of alcohol and cannabis. Performance impairment was characterised as 
significant and severe (Ramaekers et al., 2000). In a follow up study one year 
later Lamers and Ramaekers, (2001) failed to demonstrate measurable 
impairment as they purposely used a low dose of cannabis that had previously
-28-
been shown to induce no impairment to driving in recreational cannabis users. 
Their aim was to assess the levels of impairment measurable when small doses 
of cannabis and alcohol were used at the same time. The authors discuss that 
when cannabis and alcohol were given in combination subjects were “slightly 
impaired” however, this did not reach significance (Lamers and Ramaekers, 
2001). The authors also stated that subjects were less able to detect peripheral 
traffic, and that they either chose to, or were unable to divide their attention 
between the peripheral traffic and the central driving task. Subjects therefore 
decided to ignore the peripheral traffic in favour of principal driving manoeuvres 
(Lamers and Ramaekers, 2001). The study reported that subjects felt less alert 
and made more effort whilst driving in the cannabis conditions, thus stating that 
they were aware of their impairment and made adjustments accordingly (Lamers 
and Ramaekers, 2001). The authors attempted to explain the discrepancy with 
their previous publication. Their previous study used a car following task and a 
road tracking task (Ramaekers et al., 2000). Together these tests assessed 
driving components such as road tracking, speed adjustments, distance keeping, 
and breaking. The task that was used to assess poly-drug effects was the city 
driving test; subjects were assessed on observation and understanding of traffic, 
risk assessment and planning. The authors argue that this latter task was 
particularly demanding requiring laborious information processing and attention 
capabilities, as such, processing of the task is slow but flexible, and as such 
more robust to the consequences of small amounts of impairment. Conversely, 
the driving tests that were used in the 2000 study assess automatic routine 
processes that can be carried out in a fast and effortless manner, therefore more 
susceptible to disruption.
-29-
Although the general consensus seems to be that when used in combination, 
alcohol and cannabis produces severe impairment other findings aren’t 
consistent with this. Liguori et al., (2002) found that although cannabis and 
alcohol did significantly impair brake latency this was not an additive 
relationship, the effects were no greater than the effects of alcohol alone. Once 
again the authors attribute the lack of findings to subjects increased caution 
whilst under the cannabis conditions. (Liguori et al., 2002). This study also 
demonstrated that subjects equilibrium, assessed using body sway measures 
were significantly impaired following cannabis use, and the effect of cannabis 
when dosed in combination with alcohol were also significant.
The studies presented here lead to the conclusion that cannabis does impair 
driving ability in doses ranging from 200-300pg with doses lower than this 
showing a trend towards poorer performance. The studies that assessed actual 
driving performance demonstrated driving impairment when cannabis was taken 
alone; this impairment was exacerbated when taken in combination with alcohol. 
Studies which assessed distinct psychomotor abilities also demonstrated a 
measurable impairment (Chait and Perry, 1994; Kurzthaler et al., 1999) not 
compatible with safe driving.
1.5.3 Heroin
This review highlighted just two peer reviewed studies. Although outside of the 
restrictions of the literature review due to the year of publication it is important 
that these two studies are discussed, in particular to highlight the lack of 
evidence in this area. Smith et al., (1962) reported significant performance 
decrement in sustained attention and information processing. The authors
-30-
concluded that the impairment produced by heroin appeared earlier and was 
more severe that that produced by morphine. This is why caution should be 
applied when using morphine studies in place of heroin studies to explain the 
performance effects of heroin abuse. Conversely to Smith et al., (1962), Fraser 
et al., (1964) reported no significant performance decrement in measures of 
attention in comparison to placebo. The authors conclude that neither acute 
doses nor an induced period of addiction (60 days) impaired mental tasks which 
required close and sustained attention. Although this study used the higher 
dose of the two studies, 8mg delivered intravenously, the subject sample were 
heroin addicts, whereas in Smith et al., (1962) subjects were healthy volunteers. 
This highlights the complications and ethical considerations when evaluating 
empirical evidence of performance decrements due to illegal drugs.
These studies highlight two main issues. The novice (healthy) users 
experienced cognitive and psychomotor performance decrement whilst under 
the influence of heroin; however the addicted subject sample experienced no 
such decrement. There is the argument that this may be due to the fact that 
baseline measures were collected in a state of withdrawal therefore subject’s 
performance reverted to normal functioning post dose. Under current guidelines 
and UK law both of these studies would be viewed as unethical. One study 
dosed naive subjects, the other induced an addiction cycle in former addicts. 
Neither of these studies would be conducted today however, there must be 
scope to enrol drug users seeking treatment to participate in driving research to 
gain a clearer picture of any impairment involved.
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1.5.4 Cocaine
Overall most studies present the picture that typically, cocaine use does not 
produce significant impairment in comparison to placebo or a control group. If 
significance is demonstrated then it is in the direction of improvement to 
cognitive and psychomotor functioning. Neither Fillmore et al., (2002), Stillman 
et al., (1993), nor Johnson et al., (1998) were able to demonstrate that cocaine 
had a significant effect on complex reaction time. These studies used a range of 
doses from 0.650mg to 150mg. The doses reported in all of the studies 
displayed in Table 1.3 were low. This was particularly demonstrated in Fillmore 
et al., (2002) as the doses had little effect on subjective ratings of drug 
intoxication. Studies that have used higher doses, 300mg for example may find 
more robust effects (Fillmore et al., 2002). Stillman et al., (1993) used the 
biggest group of subjects (n=13), and tested them for the longest period post 
dose (4 hours). Although not significant the authors describe how subjects 
dosed with cocaine showed greatest improvement in reaction time in comparison 
to placebo, improving on average by 26ms, and that this improvement endured 
the entire four hours post dose. However, this improvement in speed response 
was associated with a deficit in attention. The authors conclude that this speed 
attention trade-off in the real world is deleterious to successful task execution.
Higgins et al., carried out a study in 1990, which was repeated in 1993 looking at 
information processing following cocaine use. In 1990, the authors were unable 
to demonstrate an improvement in performance on the Digit Symbol Substitution 
Task (DSST), which they argued, was due to the fact that subjects were well 
trained prior to testing which left no room for improved performance post dose. 
However, a replication of the study in 1993 demonstrated a significant
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improvement in performance for subjects dosed with 1.37mg/kg of cocaine but 
not for those dosed with 0.057 or 0.69mg/kg. Higgins et al., (1993) also looked 
into the effect of poly-drug use on behaviour.
Three studies investigated the cocaine/alcohol interaction and its effects of 
cognitive and psychomotor functioning. The poly-drug use of alcohol and 
cocaine has a significantly impairing effect on information processing skills; 
Farre et al., (1993) and Foltin et al., (1993), demonstrated this. Only Higgins et 
al., (1993) reported a significant improvement in performance with 48mg/kg of 
cocaine and 0.5g/kg of alcohol. In the Higgins et al., (1993) study complex 
reaction time was consistently unaffected by the concurrent use of cocaine and 
alcohol. Once again, based on the information uncovered in the literature review 
it is difficult to form a conclusion as to the impairing effects of cocaine alone and 
in combination with alcohol on measures of cognitive and psychomotor 
performance related to driving ability. In 1993 Foltin et al., described how 
cocaine and cannabis were common poly-drug combinations, and as such 
wanted to shed light on the impact that the concurrent use of the two substances 
would have on behaviour. No significant effects on performance were 
demonstrated. The authors explained these findings by acknowledging that the 
study used a small sample size (n=5), which may have led to an underestimation 
of the performance decrements produced when these two drugs were taken 
together. In addition, the authors highlighted that the subject sample had 
histories of recreational drug use and therefore may have been tolerant to the 
doses of drug used in the study. The authors also evaluated the psychometric 
tests that they used postulating that the duration of the tests, the actual tests
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selected, and the times they were carried out, were additional factors which 
contributed to the non significant findings.
1.5.5 Amphetamine
Overall most of the studies to date suggest that amphetamine and 
methamphetamine use have no significant detrimental effects on driving related 
skills. Pickworth et al., (1997) and Cami et al., (2000) failed to find any 
significant performance impairment of 10mg, 30mg or 40mg of amphetamine in 
comparison to placebo. Johnson et al., (2005) reported performance 
enhancement of sustained attention and information processing and a lowering 
of complex reaction time, following 15mg and 30mg of methamphetamine in 
methamphetamine dependent subjects. The study demonstrated that these 
performance effects were maintained until the end of the experimental phase 
(approximately 180 minutes post dose).
Mendelson et al., (1998) also studied experienced methamphetamine users in 
laboratory conditions to assess the poly-drug effects of methamphetamine and 
alcohol. Subjectively subjects reported feeling more alert, relaxed, stimulated 
and euphoric however no significant performance effects were reported for the 
objective measures of performance. In fact, complex reaction time showed a 
non significant effect for faster reaction times following the methamphetamine 
dose. Although no significant differences were measured, there was a trend for 
methamphetamine to reverse or antagonise the effects of alcohol. Mendelson et 
al., (1998) discussed that the lack of significant effects on the tests may have 
been due to that fact that 30mg of methamphetamine is a relatively low dose for 
regular methamphetamine users, and therefore doses were too small to detect
differences. Cami et al., (2000) advised caution in extrapolating their results to 
more complex performance tasks such as car driving. Drug users often consume 
drugs in combination with alcohol and cannabis, which produces known 
decreases in performance and associated traffic risk.
Although this review does support the belief that use of stimulant drugs 
enhances performance on some tasks, none of the study designs employed a 
simulator or an on the road assessment. Although specific skills are enhanced 
by amphetamine use, when these skills are required to work in tandem, or whilst 
successfully coping with distracters, it is possible that driving ability will be 
disrupted.
1.5.6 Ecstasy
From the results of the current literature it has not been possible to reach a 
definitive decision about whether acute ecstasy use has an impairing effect on 
driving ability or aspects of behaviour related to driving ability. Brookhuis et al., 
(2004) was the only study that assessed actual driving behaviour. It was 
reported that a single dose of MDMA did not greatly affect lateral and 
longitudinal vehicle control, however following multiple drug use accident 
involvement and causation rose by 100%, and 150% respectively. This is of 
particular relevance as ecstasy users will typically take two or more doses in one 
sitting (Steele et al., 1994) and number of crashes has been shown to be the 
ultimate indicator of driving safety (Brookhuis et al., 2004).
Two studies reported improvement in performance following doses of ecstasy. 
Lamers et al., (2003) assessed a range of psychomotor skills and reported that a
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single dose of MDMA significantly improved tracking performance, divided 
attention during a tracking task, and reaction time. The only facet of 
performance that was significantly impaired by a single dose of MDMA was 
divided attention during an estimation task. The authors discuss the conflicting 
results of the divided attention tasks and conclude that whilst the divided 
attention component of the tracking task was focused more on psychomotor 
capacity the movement estimation task was more concentrated on cognitive 
components, i.e. time estimation, which leads to increased risk taking and 
impaired traffic safety (Lamers et al., 2003). Ramaekers and Kypers (2006), 
also reported a decrease in reaction time implying the dose of MDMA had a 
performance enhancing effect. Other studies included in the literature review 
assessed a smaller spectrum of psychomotor performance. Vollenweider et al., 
(1998) and Cami et al., (2000) reported no significant performance effects when 
subjects were dosed with MDMA. Both studies were cross-over placebo 
controlled designs, using novice and recreational drug users respectively. 
Parrott and Lasky (1998) reported on performance in comparison to a pre-drug 
baseline and concluded that acute doses of MDMA impaired information 
processing. The authors particularly highlighted the implications that this would 
have for driving behaviour (Parrott and Lasky, 1998).
An underlying theme that has emerged is that although explicit measurement of 
individual psychomotor components did not produce consistent results subjects’ 
ability to perceive and predict motion was impaired, transferring to the inability to 
judge when another car would collide with their own. This ability depends on 
adequate visual perception, which has been shown to be impaired, relatively
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consistently (Brookhuis et al., 2004; Cami et al., 2000; Farre et al., 2004; 
Hernandez-Lopez et al., 2002; Lamers et al., 2003).
A possible explanation as to why the studies reported here failed to demonstrate 
the impairing ability of ecstasy is the doses of MDMA administered (Lamers et 
al., 2003). The normal average dose has been identified as 120mg (Logan and 
Couper, 2001). Additionally, poly-drug use is particularly well documented in 
ecstasy users (Lamers et al., 2003) commonly with cannabis, alcohol and 
amphetamine (Lamers et al., 2003). This review highlighted two poly-drug 
studies which reported on the investigation of the combined acute use of ecstasy 
and alcohol. Ramaekers and Kypers, (2006) reported no significant findings 
when the performance of subjects was assessed following doses of MDMA and 
alcohol. Hernandez-Lopez et al., (2002) did report significant impairment to 
information processing capability; however, they reported that the visual 
exophoria induced by the sedating effects of alcohol were in part reverted by the 
combined dosing of alcohol and MDMA. However, the authors are quick to 
explain that although their results “seem” relevant to road safety, as the study 
used laboratory based tests only, extrapolation of results is limited (Hernandez- 
Lopez et al., 2002).
Other factors particular to ecstasy use which were not included as part of the 
literature review criteria are factors such as the associated dehydration that goes 
with ecstasy use as well as the physical exhaustion, and lack of sleep that 
would affect performance in real life settings (Lamers et al., 2003).
-37-
1.6 Conclusions
Empirical evidence relating to the effects of illegal drugs on aspects of 
performance related to driving is scarce. It is clear from this review of the 
literature that all of the drugs discussed; cannabis, heroin, cocaine, 
amphetamines, and ecstasy have the ability to significantly impair aspects of 
performance related to driving ability but it would be inappropriate to conclude, 
based on these studies discussed here that all illegal drugs pose a significant 
detrimental effect to driving safety. The literature review provided a summary of 
what is known about the illegal drugs and driving, it also provides a summary of 
what further research is needed. It is essential to take into account the whole 
picture of illegal drug use, in particular the increase in confusion, willingness to 
take risks, impaired ability to make judgements rationally, and think critically. 
Also, a commonality with most of the illegal drugs is the over stimulation caused 
in the individual during the acute phases, followed by extreme exhaustion in the 
elimination phases. When empirical evidence is combined with epidemiological 
data it is possible to conclude that illegal drugs pose a real and significant threat 
to driving safety. From a combination of epidemiological and empirical data it is 
also possible to conclude that the principal drugs of concern are cannabis, 
heroin, and the amphetamines. Representation of these users on the road will 
also depend on other factors, for example it is estimated that in the UK there are 
3 million cannabis users, this is in comparison to the 650,000 amphetamine 
users and the 40,000 heroin users (Morris, 2006). Poly-drug use poses the 
greatest danger due to the synergistic or iterative drug effects caused.
Therefore illegal drugs can impair driving performance. Such impairments can 
have an enormous impact on society at large, both economically and morally.
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Consequently, the detection of the presence and magnitude of impairment have 
become major concerns. As the current law requires proof of drug induced 
impairment, not drug intoxication, a need exists for an objective tool that can be 
used to demonstrate impairment and therefore that the individual is unfit to drive.
The hypothesis of this thesis is that illegal drug use, in particular, poly drug use, 
will significantly impair an individual’s ability to carry out cognitive and 
psychomotor tasks which have been shown to positively correlate with driving 
ability. The aim of this thesis is to demonstrate that by using a portable 
psychometric device, it is possible to assess the drug induced impairment of an 
individual in field conditions, and also that it is possible to predict this impairment 
from a one off test in the absence of a baseline comparator.
1.7 Research Questions
The questions to be addressed by this thesis are therefore
• Which are the most suitable psychometric tests that can be used to assess 
aspects of performance related to driving?
• Are these psychometric tests sensitive to the accepted statutory standard of 
driving impairment, i.e. can these tests pick up the impairment produced by 
80mg of alcohol in 100ml of blood?
• Are these psychometric tests sensitive to the impairing effects of illegal drug 
use when assessed in the field conditions?
• Are these tests capable of providing a one off impairment score based on 
retrospective assessment of drug use?
• Are these tests sensitive to impairment on a cohort of drug dependents?
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• Is the Field Impairment Test (FIT) a sensitive impairment measure?
• Does the combination of psychometric assessments and the Field 
Impairment Test (FIT) strengthen the ability to detect impairment?
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CHAPTER 2
THE SELECTION OF AN APPROPRIATE PSYCHOMETRIC TESTING 
METHOD - A LOGISTIC REGRESSION
2.1 Introduction
Driving whilst unfit as a result of drug intoxication is an offence, however proving 
a driver is unfit is difficult to enforce as it requires proof of impairment rather than 
proof of intoxication. Recommendations made as a result of the European 
driving research projects; ROSITA (Verstraete and Puddu, 2000) and 
IMMORTAL (Braun et al., 2002), coupled with new legislation which was 
introduced in July 2003 (Amended Section 6 of the Road Traffic Act 1967) 
allowing police officers to carry out impairment testing at the roadside, 
culminated in an urgent call for the development of an objective device capable 
of screening drivers at the roadside for signs of impairment. At present, there is 
no objective measure that is available for officers to use at the roadside to 
determine drug induced impairment.
The 2003 amendment to the 1967 Road Traffic Act stipulated that an impairment 
assessment device could be used on drivers at the roadside whose Blood 
Alcohol Concentration (BAC) registered below the legal limit, but whose manner 
of driving in the opinion of the attending officer, was suggestive of impairment 
due to drink or drugs. If the results obtained from the device indicated that the 
driver was "unfit" or "impaired", the driver would be arrested and taken to the 
police station for evidential testing (Road Traffic Act 1967). There are a number 
of challenging objectives to be met when attempting to develop a portable driver 
impairment assessment device, capable of assessing impairing stimulant or
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depressant drug-induced effects. The IMMORTAL report detailed the following 
(Clark and Riedel, 2000);
• The adherence to psychological principles such as validity, reliability, 
sensitivity and objectivity
• Maintenance of data integrity
• Unambiguous test outcomes
• Ability to assess all aspects of driving such as attention, vigilance, 
perception, spatial and temporal processing, reaction time and 
psychomotor co-ordination
• Language free, therefore not inclusive of any verbal material
• Suitable for use by all users, including drivers, test administrators, 
legislators and the general public
• Standardised administration. The instructions have to be standardised to 
ensure the test is used in the same way by different personnel
• Easy to administer especially for personnel with a low knowledge or 
experience of psychometric testing
• An explained practice effect. It is accepted that all methods of 
psychometric assessment will involve some practice effects, however the 
extent of practice effect should be characterised
• The tests should be short in duration. Long tests would disrupt traffic flow 
and be less practical to administer at the roadside
• Valid population norms. Norm collection must be of a specific size and 
type to be representative of the population
• Insensitive to environmental effects. It is not possible to control the 
testing environment, therefore factors such as weather, light levels, noise
-42-
levels and time of day should not exert an influence over test 
performance
• Insensitivity to personal factors such as age and gender. Traits such as 
personality and intelligence, or states such as mood and anxiety should 
not affect the results of the tests.
• The equipment should be easy to use, small and robust
All of the above points must be addressed in order to develop a viable portable 
psychometric device for assessing drug induced driver impairment. In the first 
instance data from the Human Psychopharmacology Research Unit (HPRU) was 
used as a starting point to determine which psychometric tests, from an 
extensive battery of tests were the most sensitive to drug effects. The data was 
collected during a double blind placebo controlled crossover study investigating 
the effects of pregabalin (450mg), alprazolam (3mg) and placebo on cognitive 
and psychomotor function. Alprazolam was used as a verum (positive internal 
control), with each subject acting as their own control. Alprazolam is a 
triazolobenzodiazepine derivative known for its impairing effects on cognitive 
and psychomotor function. It is used therapeutically to treat anxiety, and is 
generally administered 1-3mg daily, with a total daily dose of 4mg. Although it is 
listed as a therapeutic and not illegal drug, benzodiazepines are known to be a 
problem in road safety (Hindmarch, 1983; Subhan et al., 1986; Rush and 
Griffiths, 1997; Holland et al., 1999; Verster et al., 2002) and are prone to abuse 
potential (Cole and Orzack, 1988; Jones et al., 2004; Rush et al., 2004; Wolf et
C,
al., 2005). Due to the empirical evidence of impairment and abuse potential of 
alprazolam, data from this study was used to create a statistical model to 
establish which of the psychometrics used were most capable of detecting
cognitive and psychomotor impairment. The data presented contains a variety 
of psychometric tests most commonly used in psychopharmacological 
assessment. These assessment techniques have been reviewed elsewhere and 
have been shown to bear relation to skills employed whilst driving (Ramaekers, 
2004).
2.2 Methodology
2.2.1 Study Design
The study was approved by a local research ethics committee and was 
conducted in accordance with the principles enunciated in the Declaration of 
Helsinki, as amended in October 1996. The study was a randomised, double­
blind, placebo controlled crossover study with 24 healthy subjects. Each subject 
received all of the treatments. The treatments under investigation were: 
pregabalin 150mg t.i.d, alprazolam 1mg t.i.d, and matching placebo t.i.d. Each 
treatment consisted of three days of double blind dosing followed by one day of 
single blind placebo. The drug free period between treatments was seven days. 
Performance was assessed at baseline and at 1, 3, 6, 9 and 12 hours following 
drug administration.
The primary objective of the study was to assess the effects of pregabalin and 
alprazolam and placebo on cognitive and psychomotor function as assessed by 
Critical Flicker Fusion (OFF), Hicks Choice Reaction Time (H-CRT), Continuous 
Tracking Task (CTT), Short Term Memory Task (STM) and Rapid Visual 
Information Processing (RVIP). This study was conducted in 1999 (Hindmarch 
et al., 2005), however for the purpose of this chapter the data was used for the 
statistical modelling of the discriminant analysis and logistic regression.
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2.2.2 Study Population
Healthy male and female volunteers who satisfied the following inclusion and
exclusion criteria were enrolled onto the study.
2.2.2.7 Inclusion Criteria
• Aged between 18 and 50 years inclusive
• In good health as determined by medical history, electrocardiogram 
(ECG), haematology, and blood and urine chemistry, and physical 
examination by a doctor
• Normal and stable electroencephalogram (EEG)
• A regular sleep wake cycle
• Able and willing to give informed consent
• A body mass index greater than or equal to 18 and less then or equal to 
30
• Having the consent of the volunteer’s practitioner
2.2.2.2 Exclusion Criteria
• Concomitant psychotropic medication
• Clinically significant (as judged by the investigating clinician) use of 
psychotropic medication in the last 3 months
• The use of any other medication in the preceding two weeks with the 
exception of oral contraceptives and nonsteroidal analgesics and 
paracetamol
• Significant history of mental illness, significant drug allergy, malignancy, 
or chronic drug abuse (including alcohol)
• Significant cardiovascular, respiratory, hepatic, renal, gastrointestinal, 
endocrine, neurological or haematological disease or abnormality
• Defined laboratory, biochemical, haematological abnormalities not 
including isolated abnormalities which are considered to be clinically 
significant by the physician
• Any subject with known hypersensitivity to any of the study treatments
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• A sleep/wake cycle (e.g. shift work), liable to prejudice the results of the 
study
• Pregnant or lactating females, and females of childbearing potential not 
using effective contraception
• Subjects who habitually smoked more than five cigarettes a day
• Current participation in another clinical trial, or participation in the clinical 
trial within 90 days
• Any subject the study physician judged unsuitable
2.2.3 Study Procedures
Volunteers were thoroughly trained and familiarised with the psychometric tests 
in order to minimise learning effects before proceeding with the study. Six 
training sessions were carried out in accordance with data presented on 
performance plateaus for the CFF and CRT (Parkin et al., 1997). On each day 
subjects were woken at 07:00 and performed the battery of tests, assessment 
on Day 1 providing baseline assessments. Further assessments were made at 
1, 3, 6, 9 and 12 hours following the first dose. On Days 2 and 3 study treatment 
was administered at 09:30, 14:30 and 20:30. On day 4 placebo was 
administered at 09:30, 14:30 and 20:30 in order to observe any hangover effects 
of the drugs.
2.2.4 Psychometric Assessments
2.2.4A A Divided Attention Motor Co-ordination Task
The Continuous Tracking Test (CTT) was an interactive task of psychomotor 
function involving parallel information processing (Parkin et al., 1988). Subjects 
were required to keep a cursor in alignment with a moving target while 
simultaneously responding to randomly presented visual stimuli in the peripheral 
field of vision. This task generated two response measures of performance:
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tracking accuracy, measured as the root mean square deviation of movement of 
the cursor from the target stimulus, and mean reaction time to the peripheral 
stimulus. The task was five minutes in duration.
2.2.4.2 A Reaction Time Task
The Choice Reaction Time task (Hindmarch, 1975) was used as an indicator of 
sensorimotor performance, assessing the subject’s ability to attend and respond 
to critical stimuli (Sherwood and Kerr, 1993; Hindmarch et al., 2002). The 
subjects were required to extinguish one of six equidistant red lights by pressing 
the associated response button as quickly as possible. There were 48 trials 
presented per test. Mean reaction time in milliseconds was recorded for three 
components; recognition, motor, and total reaction time. Recognition reaction 
time (RRT) was the time it took for the subject to notice the light; being the time 
between stimulus onset and the subject lifting their finger from the start button. 
Motor reaction time (MRT) indexed the movement component of this task, and 
was the time between the subjects lifting their finger from the start button and 
touching the response button. Total reaction time (TRT) was the sum of RRT 
and MRT and used as an indicator of sensori motor integrity. All of the response 
measures were measured in milliseconds.
2.2.4.3 An Information Processing Task
The Rapid Visual Information Processing Task (RVIP) was used. The RVIP was 
used to assess the subject’s ability to sustain their attention to periodically 
occurring events, i.e. sustained attention under variable demand (Wesnes and 
Warburton, 1984). Subjects were required to monitor a series of single numbers 
(1-9) appearing consecutively on the screen at a rate of 100 digits every minute,
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and respond to sequences of three odd or three even numbers. The response 
measures were the number of valid responses, and the reaction time of these 
responses (RT-RVIP) was measured in milliseconds. At each assessment, the 
duration of this task was 10 minutes.
2.2.4.4 A Short Term Memory Task
The short term memory (STM) task was used to assess subject’s proficiency at 
high speed scanning, and retrieval of information from short term memory 
(Sternberg, 1975). Subjects were required to memorise a random series of two, 
four or six letters (the stimulus set), which were presented sequentially at a rate 
of 1.2 seconds per letter. One second after the final digit of the stimulus set was 
presented a visual warning signal was presented. Twelve probe digits then 
followed this; subjects were required to indicate whether each probe digit was 
contained within the original stimulus set. The rate of presentation of the probe 
digits was determined by the subject’s rate of response. Two trials of each 
stimulus set size were carried out. The response measures used in analysis 
were valid responses to the probe digits, and reaction time of the valid 
responses measured in milliseconds.
2.2.4.5 A Sensory Task
The Critical Flicker Fusion task (CFF) provides an index of central nervous 
system activity (Gortelmeyer and Weimann, 1982), and specifically, a 
quantitative measure of a subjects "vigilance and cortical arousal" (Levander, 
1982). Subjects were required to distinguish between discrete sensory events by 
discerning flicker from fusion and vice versa of four light emitting diodes (LEDs). 
The diodes are arranged in a one centimetre square on a black background and
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held in foveal fixation at a distance of one metre. Individual thresholds were 
determined by the psychophysical method of limits on four ascending (flicker to 
fusion) and four descending (fusion to flicker) scales (Woodworth and 
Schlosberg, 1958). Significant changes in CFF threshold are associated with 
changes in efficiency, capacity and arousal. An increase in CFF would indicate 
inflated CNS arousal whereas a reduction would be associated with cognitive 
impairment and sedation (Hindmarch, 1980; 1982).
2.3 Results
Twenty-four subjects were enrolled into the study; one subject was withdrawn 
prior to dosing. The remaining 23 subjects completed all of the study 
procedures and were included in the initial analysis. 11 (48%) of the subjects 
were male and 12 (52%) were female. Statistical analysis software SAS PC 
(Version 8 , SAS Institute, CARY, NC, USA) was used to carry out the statistical 
analysis). A five way analysis of variance demonstrated that alprazolam (3mg 
t.i.d) significantly impaired cognitive and psychomotor functioning. The ANOVA 
model included the following factors; subjects, period, and treatment (i.e. 
alprazolam or placebo) together with day and time. The factor subject included 
the response measures collected from all the psychometric tests, period was 
included as a factor in the ANOVA as the study was a cross over, this would 
allow for environmental changes to be accounted for. In this ANOVA model 
treatment refers to which drug the subject was dosed with, day was included as 
each period contained four separate testing days, and time was also included to 
account for the five different test points that were carried out on each day. The 
analysis was two-tailed, at the 5% level of significance, and Bonferroni adjusted 
for multiple comparisons. Alprazolam was shown to significantly reduce fine
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motor control as demonstrated by reduced tracking accuracy (P<0.0001) and 
significantly increase reaction time assessed using the CTT (P<0.0001), CRT 
(MRT, RRT and TRT all P<0.0001), RVIP (P<0.0001) and STM (P<0.0001). 
Alprazolam was also shown to impair a subject’s ability to sustain their attention 
significantly reducing correct responses on the RVIP (P<0.0001). Short-term 
memory functioning was also affected by 3mg of alprazolam significantly 
increasing the time taken to make a correct response (p<0.0005). The drug was 
also shown to significantly impair CNS arousal assessed using the CFF task 
(p<0.05).
2.3.1 Methodology for the Selection of the Most Sensitive Psychometric Tests 
In order to begin the process of devising an objective tool that can be used at 
the roadside, data from this alprazolam study was used to carry out a logistic 
regression. Using both the pre and post dose assessments the response 
measures from the tests discussed above, were added step-wise, to determine 
whether test inclusion strengthened overall sensitivity to the effects of 
alprazolam. This was necessary in order to identify the most sensitive tests to 
drug induced impairment.
In order to mirror the roadside requirement of retrospective determination of drug 
use a discriminant analysis was then carried out to test whether using the 
variables identified by the logistic regression, it was possible to predict whether 
or not alprazolam had been administered based solely on test performance .
-50-
2.3.1.1 Logistic Regression
A logistic regression would allow one to predict a discrete outcome, such as 
group membership, from a set of variables in much the same way as a 
discriminant analysis would. However, as the independent variables in this case 
would be defined as a mixture of continuous (the psychometric data) and 
categorical data (age group) a logistic regression was used instead of a 
discriminant analysis. As discussed, the measurements; tracking accuracy, 
tracking reaction time, RRT, MRT, TRT, RVIP valid responses, RVIP reaction 
time, STM valid responses, STM reaction time, and CFF threshold were used as 
independent variables in an incremental stepwise logistic regression, to predict 
as well as possible the following dependent variable: whether or not alprazolam 
had been administered prior to the testing procedures being carried out. The 
gender and age-group of the subjects used to generate the data being analysed 
were also available and were used in attempting to improve the prediction. 
However, only gender produced a noticeable improvement when used in 
combination with some of the psychometric measurements mentioned above. 
The stepwise logistic regression, using Akaike’s Information Criterion (AIC) 
(Akaike, 1974) to minimise the risk of over-elaborating the model, selected the 
following psychometric test variables as the significant predictors of alprazolam 
induced impairment: tracking accuracy, RVIP valid responses and TRT. The 
tracking accuracy of women had no effect on the model, however for men a 
coefficient estimate of 0.18 (s.e. = 0.07) was demonstrated. A coefficient 
estimate for RVIP valid responses of -0.05 (s.e. = 0.02) was reported. For TRT 
a coefficient estimate of 0.01 (s.e. = <0.01) . Therefore the cognitive and 
psychomotor skills that were shown to be most sensitive to drug induced 
impairment were motor co-ordination, information processing and reaction time.
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2.3.1.2 Discriminant Analysis
The major purpose of a discriminant analysis is to predict membership in two or 
more mutually exclusive groups from a set of predictors, when there is no natural 
ordering on the groups. In this case a discriminant analysis model would allow a 
method of retrospective prediction of drug use derived from psychometric test 
performance. The possibility of being able to predict from a test score whether 
an individual is responding in the same manner as the normative group, or 
conversely to it, is the corner stone of the success of an impairment assessment 
device which can provide meaningful results at the roadside. Cross validation 
showed that by varying the probability level for prediction it was possible to 
accurately predict 72% of those subjects who had been dosed with alprazolam 
(probability level 0.0440). However at this probability level 21% of those in the 
placebo group were wrongly predicted as having taken the drug. It was possible 
to vary the probability level to reduce the number of people incorrectly selected, 
for example a probability level of 0.8 results in only 1% of false positives with 
39% of the alprazolam group correctly identified. A probability level of 0.36 
produced only 8% false positives and 72% were correctly identified into the 
alprazolam group. Further studies with alcohol and illegal drugs will provide 
further data which can be used to “fine tune” the model, to produce an accurate 
and sensitive method of detecting drivers who are impaired.
2.4 Conclusions
The results demonstrated that a reaction time task, an information processing 
task, a divided attention motor task, and a sensory assessment task were 
sensitive to drug use, and that the response measures of these tests could be
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used to predict whether or not a subject had previously taken an impairing 
psychoactive drug. Further analysis of the alprazolam data demonstrated that 
the analysis model developed was able to predict, from a relatively small sample 
group (n=24), up to 70% of those who had taken a prescription drug. As all of 
the psychometric tests used on this study were sensitive to the effects of drug 
induced impairment, the specialised requirements of a roadside screening 
device identified in the IMMORTAL report (Clark and Riedel, 2000) were used to 
facilitate the decision making process as to which tests would be most suitable. 
Due to the literacy and numeracy skills required to successfully complete the 
tasks, it was probable that the RVIP and STM would not be appropriate tests to 
use for roadside screening. However, there is supporting literature that attention 
and information processing are central components essential for the successful 
completion of many tasks, including driving (Patat, 1998). The literature also 
concludes that errors of attentional efficiency are the most frequently highlighted 
determinant of accident causality (Riedel et al., 1998b). Therefore a sustained 
attention task with an added reaction time component, which contained no 
literacy or numercy capabilities was required. The Sustained Attention to 
Response Task (SART) is a psychometric task which has been used to assess 
sustained attention, attentional failure, and routine response control (Manly et 
al., 1999; 2000). Errors that are made during completion of the task are used as 
a measure of the individual’s capacity to resist drifting into an automatic style of 
responding. Researchers who support the use of the task argue that the task 
can be used to predict an individual’s accident proneness (Robertson et al., 
1997; Manly et al., 1999; 2000; 2001). Tracking tasks are particularly vulnerable 
to internal factors that slow information processing, and have been shown to be 
a sensitive task for revealing impairment to a number of psychoactive agents
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including alcohol and marijuana (Hindmarch et al., 1991; Robbe, 1998; 
Moskowitz and Fiorentino, 2000). Validation of tracking tasks to assess aspects 
of fine motor control has been discussed in the literature (Jex and McDonnell, 
1966) as have tracking tasks combining motor control assessment with divided 
attention assessment, a method validated in the early 1970’s (Moskowitz, 1973). 
As a consequence of both the available literature, and the results obtained from 
the logistic regression, a tracking task was selected to be included in a roadside 
screening battery, albeit with an appreciation that initially different models may 
need to be employed for men and women. The following tasks, in the following 
subsections were selected for development.
2.4.1 A Critical Tracking Task (CTT)
The tracking task that was developed for this thesis was an integrative task of 
cognitive and psychomotor function, comprising of tracking ability, divided 
attention, and reaction time. The user was required to track a moving object 
with a pen like stylus across the touch sensitive screen on a Personal Digital 
Assistant (PDA). At the beginning of the task, in order to cue the subjects as to 
whether they were performing correctly, the target took the form of a circle 
outline. Once the subject had made sufficient contact with the screen, the target 
turned into a shaded circle; whenever contact with the screen was broken the 
target became a circle outline once again until sufficient contact was re­
established. The target circle measured 4mm in diameter, the response 
measures were; mean tracking deviation (calculated as the root mean square of 
the difference between the centre of the target and the position of the stylus) and 
mean tracking deviation at what was called the “critical” section of the task. A 
"critical" tracking section was introduced towards the end of the task where the
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target sped up to such a degree that it became impossible for the subject to 
track accurately, forcing performance to break down. A divided attention 
component was included in the task with simultaneous presentation of stimuli in 
the periphery of the PDA screen. Subjects were required to respond to the 
stimuli with a key press at the same time as maintaining the tracking task. The 
periphery stimuli was a small road sign symbol (1cm2). This represented the 
divided attention component of the task; the response measure being the mean 
reaction time to presented stimuli. A further response variable was investigated, 
mean tracking deviation following response to a peripheral stimuli. This 
demonstrated how long the subject took to return to the primary task. The task 
was programmed to last for six minutes and all data was captured electronically.
2.4.2 The Sustained Attention to Response Task (SART)
In conjunction with motor control and reaction time, attentional performance is 
also an important information processing ability essential for successful driving 
(Riedel et al., 1998a; Riedel et al., 1998b). A sustained attention task that does 
not rely on numeracy or literacy is the Sustained Attention to Response Task. 
This task assesses sustained attentional performance and has been shown to 
be a good predictor of every-day attentional failures (Manly et al., 1999). 
Continuous stimuli in the form of road sign images (1.5cm2) were presented at a 
rate of one sign every 1105ms until 243 signs had been presented. Subjects 
were instructed to respond to the presentation of every stimulus with a key press 
unless presented with the target stimulus in which case they were instructed to 
withhold response. Before commencing the task subjects were informed that 
the target stimulus was a predefined “no parking” road sign and were prompted 
after a wrong response. The response measures were the number of incorrect
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responses to the “no parking” road sign, and mean reaction time to correct 
responses. All data was captured electronically.
2.4.3 The Hardware
The tests were programmed onto a personal computer (Symbol PDT 8000 from 
Symbol Technologies) an example of which is below in Figure 2.1. The PDT 
8000 was a compact (18cm x 9cm), ruggedised hand held computing device 
with an internal backlight to enable standardised operation in all light conditions, 
and a touch sensitive screen measuring 8 cms x 6 cms. The entire test battery 
was 11 minutes in duration, the CTT being 6 minutes long and the SART 5 
minutes long. The tracking test was presented first, immediately followed by the 
attention task. Subjects were asked to hold the device in their non dominant 
hand and to carry out the test procedures with their dominant hand (the hand 
they use to write with).
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Figure 2.1 The Symbol PDT device showing the instruction screen of the 
Sustained Attention to Response Task (SART)
This device was used as the prototype roadside impairment device in all of the 
studies carried out in this thesis. Psychometrics are traditionally presented on 
static apparatus comprising a computer screen and separate control knobs. 
Due to the reduced size of the roadside apparatus the first question that needed 
to be answered was whether psychometrics presented on this alternative 
medium could ellicit meaningful results. It was envisaged that this question 
could be answered by dosing subjects with intoxicating levels of alcohol and 
assessing their performance pre and post dose.
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CHAPTER 3
THE DEVELOPMENT OF A PORTABLE PSYCHOMETRIC TESTING 
DEVICE TO BE USED IN THE FIELD: THE EFFECTS OF ALCOHOL ON 
PSYCHOMOTOR PERFORMANCE IN HEALTHY VOLUNTEERS
3.1 Introduction
The measurement of drug-induced impairment using psychometric test batteries 
in the laboratory is a process recognised for being reliable, controlled, sensitive, 
safe, cheap, and convenient (Wetherall, 1996). Typically, within 
psychopharmacology, psychometric test batteries are used in strictly controlled 
environments to assess the effect a psychoactive compound may be having on 
cognitive and psychomotor skills. These effects include aspects of attention, 
information processing, memory, reaction time, and divided attention. Subjects 
undergo pre-study familiarisation of the test battery, and are then tested 
repeatedly in accordance with the strict confines of methodological and 
experimental protocols. There is no doubt that this level of control is the ideal in 
terms of scientific integrity within the laboratory, however, as the fields of 
psychopharmacology and psychometry advance, a need has arisen for 
psychometric testing to be utilised in the field (Braun et al., 2002; Verstraete and 
Puddu, 2000).
The most sensitive, commonly used, and reliable tests for assessing activities of 
daily living (with particular reference to car handling ability), are tracking tasks 
and reaction time tasks (Patat, 1998), as they have been shown to be good 
models of the perceptual cognitive demands placed on the individual 
(Moskowitz, 1984). It is widely accepted that alcohol, as well as other 
psychoactive substances, increases reaction time, reduces cognitive and
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psychomotor performance, and impairs attentional processing (Fillmore and 
Weafer, 2004; Hindmarch et al., 1991; Marczinski and Fillmore, 2005; Schweizer 
et al., 2005; Versavel et al., 2005), and therefore has a detrimental effect on 
aspects of performance related to driving ability (Farquhar et al., 2002; 
Hindmarch, 1980), and on actual driving ability (Borkenstein et al., 1964; 
Robertson and Drummer, 1994).
There is a well-established legal framework for prosecuting drivers who exceed 
the alcohol intoxication limit laid down by statute. Legal limits (80mg of alcohol 
in 100ml of blood for the United Kingdom, and a range of 20mg/100ml to 
80mg/100ml in other European countries) were set as a consequence of studies 
such as the Grand Rapids Study which convincingly demonstrated that driving 
under the influence of alcohol was an important risk factor for traffic accidents 
(Borkenstein et al. 1974). More recent wide scale epidemiological investigations 
looking at drink driving prevalence and accident involvement corroborate the 
long held view that alcohol intoxication is a major risk to traffic safety (Holmgren 
et al., 2005; Longo et al., 2000; Mura et al., 2003; Smink et al., 2001). In order to 
be able to draw initial conclusions about levels of impairment the psychometric 
test battery is able to detect, thus investigate the test’s validity, two levels 
(50mg/100ml and 80mg/100ml) of alcohol were selected. A test is valid if it 
measures what it claims to measure (Wetherell, 1996), in this case, the 
impairment brought about by alcohol. A review by Hindmarch (Hindmarch, 1980) 
found that many of the tests used in psychopharmacology lacked a history of 
reliability and validity, a sentiment echoed by Parrott (Parrott, 1991a, 1991b, 
1991c). Tracking tasks have been shown to have a long history in terms of 
reliability, validity and pharmacosensitivity (Sherwood and Kerr, 1993), and more
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specifically to be as efficient as on-the-road tests in identifying drugs which 
impeded car driving performance (Hindmarch, 1988). The sustained attention to 
response task has been shown to be a good predictor of “accident proneness” in 
patient groups as well as healthy volunteers (Manly et al., 2000; Manly et al., 
1999; Robertson et al., 1997).
The issue of validity was just one of the issues raised by Clark and Riedel 
(2000), as being an essential component for the successful creation of an 
objective impairment device that could be used at the roadside. This study will 
begin the process of assessing the validity of the two psychometric tests used in 
this thesis. Dosing healthy subjects with alcohol and using the two tests to 
assess their performance before and after the dose will provide preliminary data 
relating to the sensitivity of the tests to detect impairment and also, how reliable 
the values obtained are. In addition, this study will provide the opportunity to 
quantify the possible learning effects of the Critical Tracking Task (CTT) and 
Sustained Attention to Response Task (SART).
3.2 Study Aims
The aims of this study were:
• To assess the practice effects of the test battery. In 
psychopharmacological investigation subjects would typically be trained 
on the test battery until their performance has reached a plateau (Parkin 
et al., 1997). As the intended use of this test battery would be at the 
roadside to screen impaired drivers, ideally this test battery would have 
minimal training effects (Clark and Riedel, 2000)
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• To investigate the validity of the test battery in assessing the performance 
of healthy subjects following administration of two doses of alcohol 
(50mg/100ml and 80mg/100ml) and alcohol placebo.
• To assess the reliability of the psychometric tests, i.e. the consistency of 
an individuals performance over time. At the roadside there would be no 
opportunity to carry out baseline assessments. It is therefore essential to 
be able to gain meaningful results from one set of measurements. An 
assessment of the device’s reliability would allow statements to be made 
about the reliability of a one off measurement.
The study would also provide an indication as to the practical feasibility of 
administering psychometric tests with a portable device.
3.3 Methodology
3.3.1 Study Design
The study was a randomised, double-blind, placebo-controlled, crossover 
design. Those subjects who satisfied the entry criteria, and provided written 
informed consent were enrolled onto the study. Subjects took part in three one- 
day treatment sessions, separated by at least a 24-hour washout period to 
ensure no carry-over effects. All subjects received doses of alcohol to achieve 
blood levels of 50mg/100ml of alcohol, 80mg/100ml of alcohol or alcohol 
placebo as a single dose across three treatment sessions. The order of 
administration was randomised using a Latin square design.
At the start of each treatment session, all of the subjects were breathalysed and 
female subjects provided a urine sample to be tested for pregnancy. Evidence
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of alcohol consumption or pregnancy prior to the start of an assessment day 
were criteria for subject withdrawal. Subjects then completed a set of baseline 
psychometric tests following which alcohol or alcohol placebo was administered. 
At 40 minutes post dose, subjects were breathalysed and carried out another set 
of psychometric tests. Following completion of the testing phase, subjects were 
provided with a light meal and had a final breathalyser. Breath alcohol readings 
(BrAC) were taken using a Lion Alcometer, model S-D (Lion Laboratories) by an 
impartial assessor. For safety reasons subjects were breathalysed again before 
discharge from the unit and were only permitted to leave the unit if their blood 
alcohol (BAC) was below 80mg/100ml. Subjects were then transported home by 
taxi. This study was approved by the Quorn Research Review Ethics 
Committee.
3.3.2 Study Population
18 individuals who satisfied the inclusion and exclusion criteria were recruited 
via advertisement and provided written informed consent. Following the 
consenting process volunteers completed a Medical Health Questionnaire 
(MHQ). This questionnaire asked subjects about their medical history and was 
then assessed by the study physician. If the physician judged the subject to be 
healthy, they were permitted to continue with the study. Subjects were randomly 
allocated to a treatment group. This determined the order in which the alcohol 
doses/placebo were administered. Subjects were permitted to drop out of the 
study at any time without having to provide a reason; in tandem, the investigator 
also maintained the right to discontinue a subject should it have proven 
necessary. Study dropouts were not replaced.
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Subjects were provided with instructions which they were required to follow for 
the duration of the study:
• Diet was unrestricted but on assessment days subjects were requested 
to have a low fat breakfast (noting the restrictions on caffeine)
• Subjects were instructed to go to bed at their usual bedtime the night 
before an assessment day
• Subjects were prohibited from taking other medications during the course 
of the study except for oral contraceptives and the occasional use of 
paracetamol and non steroidal anti-inflammatories (NSAIDs). However, if 
they were prescribed any new medications (including creams, ointments, 
inhalers) or if they purchased any non prescription medications (including 
herbal remedies), for example from the pharmacy, supermarket or health 
food shop, they were instructed to report the name of the drug(s)/herbal 
preparation(s), the dose and the dates and duration of treatment at their 
next assessment visit. If a subject took any of the above medications 
they were withdrawn from the study
• Subjects were instructed to refrain from consuming alcohol for 24 hours 
prior to an assessment day and were breathalysed to ensure compliance
• Subjects were instructed not to consume any beverages containing 
caffeine, including tea, coffee, coca cola or chocolate, for 24 hours prior 
to an assessment visit
• Subjects were not permitted any nicotine containing products whilst 
attending each assessment day.
3.3.2.1 Inclusion Criteria
The inclusion criterion was as follows:
• Aged between 18 and 55 years inclusive
• In good health as determined by a Medical Health Questionnaire (MHQ)
• Able and willing to give written informed consent
• A body mass index greater than or equal to 18 and less than or equal to 
30
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3.3.2.2 Exclusion Criteria
The exclusion criterion was as follows:
• The use of any other medication in the two weeks preceding the study 
with the exception of oral, transdermal or depot contraceptives, NSAIDs 
(e.g. ibuprofen), and paracetamol
• Significant history of mental illness, significant drug allergy, malignancy or 
chronic drug abuse (including alcohol)
• Any subject with known hypersensitivity to alcohol or is teetotal
• Any subject with a known history of drug allergy
• A sleep / wake cycle (e.g. shift work) liable to prejudice the results of the 
study
• Pregnant or lactating females, and females of child bearing potential not 
using effective contraception
• Caffeine consumption which exceeded 5 cups a day (this was defined
loosely, there was no restriction on whether the subject used a cup or a
mug and cans of coke etc. would also count)
• Alcohol consumption which exceeded 21 units per week
• Current participation in another clinical trial, or participation in a clinical 
trial within the last 90 days
• Any subject that the physician, or investigator judged to be unsuitable
3.3.3 Study Procedure
At the start of the study, the subjects were given basic instructions on how to 
carry out each of the psychometric tests. They were able to choose how they 
sat with the portable device; whether they rested it on the table, their knee, or 
held it in their hand. Once this decision had been made however, they were 
required to remain consistent. To operate the device subjects were instructed to
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hold the pen-like stylus in their dominant hand and the portable device in the 
other. Each subject initially took part in a training session where the test 
procedures were explained and demonstrated by the researcher, and each test 
was carried out three times.
In each study period, subjects were breathalysed and then completed one set of 
baseline tests. Following testing subjects received a drink consisting of either 
alcohol (in the form of vodka) mixed with an equal quantity of tonic, caffeine free 
cola or lemonade. For placebo conditions subjects were provided with the same 
quantity of drink made up of mixer only. The two doses of alcohol (50mg/100ml 
the European legal driving limit, and 80mg/100ml, the UK legal driving limit) 
were calculated using an empirically derived formula based on the Adjusted 
Widmark Scale (Watson et al., 1981) with an additional adjustment based on 
empirical data from the Transport Research Laboratory (Parkes, 2003). The 
formula for males was as follows where A was age (years); H was height (cm); 
W was weight (kg); and T was the target concentration (mg/100ml) which was 
either 50 or 80mg of alcohol per 100ml of blood. The formula used to calculate 
the alcohol dose for males was;
(3.82-(0.143*A)+(0.168*H)+(0.525*W))*T/100 
The formula for females was;
(-3.67+(0.187*H)+(0.432*W))*T/100
Subjects were instructed to consume the drink within five minutes. At each 
treatment session subjects carried out baseline psychometric assessments and 
were then dosed. A second set of psychometrics were carried out at +40 
minutes post dose. Subjects were then fed, breathalysed and discharged from
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the unit. The psychometrics that were used are outlined in Chapter 2 (Sections
2.4.1 and 2.4.2).
3.3.4 Statistical Methods
Practice effects were analysed using a one way analysis of variance (ANOVA) 
ANOVA was also applied to the study data. Statistical analysis software 
packages SPSS (SPSS for Windows 6.1) and SAS PC (Version 8 , SAS Institute, 
CARY, NC, USA) was used to carry out the statistical analysis).
In order to investigate the feasibility of being able to make decisions about a 
person’s impaired performance after one assessment in the absence of a 
baseline comparison, analysis of study data was carried out twice, once where 
no adjustment was made for baseline measures and a second time with 
baseline measures. As the combination of these two tests, and their 
presentation on a small portable device was a novelty, there was no historical 
data on which to base a power calculation. In order to retrospectively assess 
the power of the study, a post hoc power calculation was carried out, the results 
of which are presented in Table 3.1. The retrospective power calculation 
demonstrated that for some of the variables the study was underpowered, and 
that therefore there was a high probability of incorrectly dismissing important 
findings. Due to the low statistical power, and as statistical significance is 
directly linked to power (and therefore sample size), effect size statistics were 
calculated in order to clarify the importance of significant or non significant 
results (Cohen, 1988). Effect size calculations are seen as an important tool 
within the behavioural sciences in the reporting and interpretation of data (Coe, 
2002). Cohen’s d is a method of calculating effect size statistics, and places
- 6 6 -
emphasis on the size of effect one intervention is having on another, rather than 
just the statistical difference, leading it is argued, to a more scientific approach 
(Wilkinson, 1999). Cohen (1988) defined effect sizes as "small, d = .2," "medium, 
of = .5," and "large, d = .8" Test-retest reliability of both the tasks was assessed 
using intraclass correlation coefficents (ICC), (Shrout and Fleiss, 1979) of 
baseline performance over the three treatment sessions for each response 
measure. This would provide useful information about each subject’s stability of 
performance following repeated exposure to the test battery. The most reliable 
intraclass correlation coefficients approach zero.
Table 3.1 A post hoc power calculation for the Sustained Attention to 
Response Task (SART) and Critical Tracking Task (CTT)
Test Response Measure Power %
SART Mean reaction time 17
Incorrect responses 92
CTT Mean tracking deviation 60
Mean reaction time 31
Mean tracking deviation at the critical section 87
Mean deviation following response to peripheral stimuli 89
A table presenting a post hoc power calculation of the main variables for the two psychometric tests, 
demonstrating that both the CTT and the SART were underpowered in the alcohol study.
3.4 Results
18 subjects consented and were randomised, and 16 completed all the study 
procedures. One subject was unwell following the first treatment administration, 
did not consume the entire drink and was withdrawn from the study. Another 
subject was excluded prior to any study procedures being carried out. Of the 16 
subjects included in the analysis, nine were male, seven were female. They 
were aged 18 to 35 years (Mean=23yrs, SD=4.5), weighed 58.8 to 104.2Kg 
(Mean=75.67Kg, SD=7.1), and had a body mass index (BMI) range of 19.2 to 
30.6 (Mean=24.8, SD=3.5). Mean blood alcohol concentration (BAC) achieved
-67-
for the 50mg% group was 52mg/100ml (SD=6.9). The mean BAC achieved for 
the 80mg% group was 92mg/100ml (SD=8.5).
3.4.1 Practice Effects
On the sustained attention task, there was no significant difference between 
performance across the three practice sessions. The variables investigated 
were the number of incorrect presses [F(3,64)=0.105, P=0.957], and reaction 
time to correct presses [F(3,64)=0.456, P=0.714]. The tracking task did display 
some learning effects; mean tracking deviation produced a significant training 
effect [F(2,39)=5.92, P=0.006], with significance appearing between the first and 
second practice session (P=0.009), but not between the second and third 
(P=1.00), (See Figure 3.1). Reaction time to the peripheral task did not show 
any learning effects [F(2,39)=1.33, P=0.277].
- 6 8 -
Fi
gu
re
 
3.1
 
Th
e 
ef
fe
ct
 o
f 
pr
ac
tic
e 
on 
the
 
Cr
iti
ca
l 
Tr
ac
ki
ng
 
Ta
sk
 
(C
TT
)
CT>
CO
C O ^ C N O O O C O M - f M O
(s|0Xjd) uogejAap Bu ^ objj uea|/\|
Th
e 
ef
fe
ct 
of 
thr
ee
 
pr
ac
tic
e 
se
ss
ion
s 
on 
me
an
 
tra
ck
ing
 
de
via
tio
n 
(±
SE
M
) 
as
se
ss
ed
 
us
ing
 
the
 
Cr
itic
al
 T
ra
ck
ing
 
Ta
sk
 
(C
TT
). 
(N
=1
7,
 *
P<
0.
05
).
3.4.2 Sustained Attention to Response Task (SART)
In order to mimic the method of use that would be employed at the roadside, 
analysis of the data was carried out where no adjustment was made for baseline 
measures; in addition, analysis was carried out with adjustment made for 
baseline measures. Analysis in the absence of baseline proved most 
interesting, as it would provide an indication as to the feasibility of obtaining 
meaningful results from a one off assessment. Both the 50mg% and 80mg% 
dose of alcohol significantly impaired the subject’s ability to effectively sustain 
their attention (P<0.01 and P<0.001 respectively, Figure 3.2). This was 
observed by looking at the incorrect presses variable. This significance was 
also demonstrated when the data was analysed with baseline measures, the 
subjects consistently demonstrated significantly more attentional slips in 
comparison to placebo performance. There was not a statistically significant 
difference in attentional performance between the two different doses of alcohol. 
The reaction time variable of the SART was one of the variables that was 
considerably underpowered (17%). It is therefore more appropriate to look at 
the Cohen’s d value to ascertain whether a dose response effect was present. 
Results suggested that when no adjustment was made for baseline measures a 
moderate effect (d=0.4) was observed between the 80mg% group and the 
placebo group, and a minimal effect was seen between the 50mg% group and 
placebo group (d=0.2). However, there was a marked effect observed on 
reaction time when performance following the 80mg% and 50mg% dose were 
compared (d=0.6). Effect size analysis therefore confirms that 66% of those 
dosed with 80mg% achieved more incorrect presses than the control group, and 
that the number of incorrect presses achieved by the 80mg% group exceeded 
73% of scores achieved by the 50mg% group. The results are presented in
-70-
Table 3.2. Calculation of the Intraclass Correlation Coefficients (ICC) 
demonstrated that the SART is a highly reliable test. Subject’s un-dosed 
performance remained stable over time. ICC calculated using baseline data 
across the three treatment sessions was high. For incorrect responses to the 
target stimuli the ICC estimate was 0.72, and for reaction time to correct targets 
the ICC estimate was 0.83
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3.4.3 Critical Tracking Task (CTT)
In order to mimic the method of use that would be employed at the roadside 
analysis was carried out where no adjustment was made for baseline measures. 
Analysis was also carried out accounting for baseline measures. When no 
adjustment for baseline measures was made there was a statistically significant 
difference observed between the 80mg% alcohol dose and placebo for a 
number of variables. Subjects found it significantly more difficult to track the 
moving target accurately (mean tracking deviation P=0.04, Figure 3.3). In 
addition, their tracking performance at the critical section of the task was 
affected; the alcohol caused their performance to break down much quicker in 
comparison to placebo conditions (tracking deviation at the critical section of the 
task P <0.00001, Figure 3.4). Subjects found it significantly more difficult to multi 
task when they had consumed the 80mg% alcohol dose (tracking deviation 
following response to a peripheral stimulus P<0.00001, Figure 3.5). This pattern 
of significance was mirrored when analysis was carried out with correction for 
baseline measures. The mean reaction time variable of the CTT was 
underpowered (31%). Cohen’s d was therefore employed once again to provide 
an indication as to the sensitivity of the variable to doses of alcohol. A marked 
effect was demonstrated between the 80mg% dose and placebo (d=0 .6), and 
also the 50mg% dose and placebo (d=0.6). Effect size analysis of mean 
reaction time response measure confirms that the reaction time of the 50mg% 
and 80mg% group exceeded 73% of the reaction time scores of those in the 
placebo group. Full results are presented in Table 3.3. Similarly to the SART, 
performance on the CTT remained stable over time. For mean tracking 
deviation the ICC estimate was high (0.9), as was the ICC for mean tracking 
deviation at the critical section of the task (0 .8), and mean tracking deviation
-74-
following a response to a peripheral stimulus (0.7), and mean reaction time to 
peripheral stimuli (0.7).
-75-
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3.5 Discussion
Both the CTT and SART have been demonstrated to be capable of 
distinguishing between the impaired performance of subjects dosed with 
80mg/100ml of alcohol in comparison to placebo. Although a literature review 
on the performance effects of alcohol is beyond the scope of this thesis, the 
results presented are in line with data published by other researchers. The 
evidence supports that alcohol consumption impairs performance on tasks 
involving complex reaction time, .motor control, concentration and attention, 
(Hindmarch et al., 1992; Hindmarch et al., 1991; Kerr et al., 1996; Kerr et al., 
1991; Ogden and Moskowitz, 2004). Only the SART, a measure of sustained 
attention, was also sensitive to the impairment caused by 50mg/100ml of 
alcohol. A literature review concluded that there was no evidence of a threshold 
of blood alcohol concentration below which impairment does not occur (Ogden 
and Moskowitz, 2004). However, significant deficits due to low doses of alcohol 
have been measured by many tests of perceptual and motor skills designed to 
assess driving skills (Starmer, 1990).
Of greatest relevance is that statistical differences were observed between 
performances of those dosed with 80mg%, 50mg% and placebo when the data 
was analysed with no adjustments made for baseline measures. This 
demonstrates that it would be possible to make judgements about an individual’s 
impaired performance after they had been exposed to the tests only once. This 
is positive as it provides preliminary evidence that the intended use of the test 
battery, to assess drivers at the roadside, could be possible. The test battery 
was also shown to have a high degree of reliability, in that an unimpaired 
individual’s performance would not improve or deteriorate following successive
-80-
exposure to the tests. The International Council on Alcohol, Drugs and Traffic 
Safety (ICADTS) conducted a working group in 1999 to provide guidelines for 
experimental studies that are specifically undertaken to determine the effects of 
drugs on driving and driving related skills. They published recommendations 
stating that laboratory tests designed to assess skills relevant to driving 
performance must possess a reliability coefficient in the absence of drug effects 
of r=0.7 (Berghaus and Friedel, 1999). All of the variables of both of the CTT and 
the SART possessed an ICC of 0.7 or above (data not shown). In addition, an 
attempt to fulfil the requirements concerning the development of a new 
psychometric test put forward by Parrott (1991a, 1991b, 1991c) is beyond the 
scope of this thesis. However, it is essential that at a point in the future, should 
the test battery continue to produce meaningful results that an attempt is made 
to fully document the reliability and validity of the battery.
The data collected here suggested that the SART had no practice effects but 
that the CTT had minimal learning effects between the first and second 
exposure to the test. This learning effect was eradicated by the third exposure. 
It is accepted that practice effects cannot be eradicated completely (Clark and 
Riedel, 2000), and that after sufficient training a plateau of performance will 
occur (Parkin et al., 1997). The final battery should incorporate a short practice 
session to familiarise the subject with the test before data collection begins, thus 
reducing the risk of practice effects being misidentified as task difficulty.
The aims of this study were to explore the reliability and sensitivity of the test 
battery. The results suggest that this psychometric test battery is a valid and 
reliable tool. Although the results presented here are positive, the device has
only been shown to be sensitive to the impairing effects of alcohol in a small 
sample of trained subjects. In the past century it has become widely accepted 
that driving performance is impaired by alcohol even in low dosage, and that 
many other drugs are also linked to driving impairment (Ogden and Moskowitz,
2004). The study of the effects of drugs other than alcohol is more complex 
because of the number of medicinals and non-medicinals of potential interest, 
the difficulties in estimating drug levels, and the complexity of drug/subject 
interactions. Ogden and Moskowitz (2004) concluded that there was no one 
test, or group of tests, which met the need for detecting and documenting 
impairment, either in the laboratory or at the roadside. In order to push 
investigation of the portable test battery discussed here further, subsequent 
investigation will need to utilise the test battery in field conditions on an 
untrained, un-drugged sample
CHAPTER 4
THE DEVELOPMENT OF A PORTABLE PSYCHOMETRIC TESTING 
DEVICE: THE EFFECTS OF ILLEGAL DRUG USE ON THE
PERFORMANCE OF VOLUNTEERS IN FIELD CONDITIONS, AND THE 
PREDICTION OF IMPAIRMENT BASED ON TEST PERFORMANCE
4.1 Introduction
Psychopharmacology is built on the premise that a psychoactive substance will 
always elicit a change in behaviour (Hamilton and Timmons, 1994) and that this 
change in behaviour is measurable. These changes are scientifically assessed 
using standardised methods of assessment, with subjects carrying out what are 
known as baseline measures -  where no drug has been consumed, followed by 
the same assessments at regular intervals determined by time of dose and drug 
absorption. Based on cross-over within subject designs, comparative methods 
of analysis compare drugged performance with baseline to characterise any 
changes in performance that are present. It is possible then to make statements 
about the impairing or enhancing effect a drug may be exerting over the 
individual. It is also possible to pinpoint which dose, and at what stage of the 
absorption process the drug is exerting strongest effect on the cognitive and 
psychomotor performance of the individual. This thesis requires this process to 
be turned on its head. This psychometric device will be required to make 
statements about an individual’s impaired performance in the absence of: a 
standardised environment; baseline measurements; time of dose; and amount 
consumed. Any statements made must be based on just one test session of ten 
minutes duration. Also, the different classes of illegal drugs have very different 
effects on the brain and body and are often taken in varying concentrations and 
combinations. This makes the likelihood of successfully developing an
impairment device that is equally capable of detecting the hyper vigilance 
induced by stimulants for example, or the CNS depression brought about 
through opioid use, highly unlikely.
The primary aim of this thesis is to establish whether it is possible to make 
statements about an individual’s impaired performance based on one test point 
and to be able to make retrospective judgements pertaining to whether this 
impaired performance is due to a psychoactive drug. Using statistical methods 
this chapter shall detail the process of developing a means of categorising 
performance as impaired or non impaired, based solely on test performance.
In order to begin to investigate whether it is possible to retrospectively assess 
drug induced impairment, subjects who had already consumed illegal drugs 
were tested in field conditions in order to replicate the use of the device at the 
roadside. Data from this study was then used in a discriminant analysis to 
investigate the possibility of predicting drug use based solely on test 
performance.
4.2 Study Aims
The aims of this study were:
• To investigate the sensitivity of the psychometric test battery to the 
performance of volunteers who had consumed illegal drugs, alcohol, or a 
combination of both, in comparison to a control sample of non-drug 
users, tested in field conditions.
• To investigate the possibility of determining drug use retrospectively 
based solely on test performance.
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4.3 Methodology
4.3.1 Study Design
This study was a field experiment carried out at two music festivals in the south 
of England in the summer of 2003, and was approved by an Independent Ethics 
Review Committee (Quorn Research Review Committee). Individuals were 
approached at the festivals and asked if they would be willing to take part. Due 
to the novel nature of recruitment, i.e. that subjects could possibly be intoxicated 
at the point of consent; researchers assessed each subject to ascertain their 
capability of understanding the consenting process. As well as the signed 
informed consent which detailed their right to withdraw from the study up to 72 
hours after taking part, each subject was also provided with a contact card 
allowing them an added option of withdrawing consent if they so desired at a 
more sober moment (no subject requested to have their data removed after 
taking part).
Upon providing written informed consent, subjects were required to take an 
alcohol breathalyser test, provide a saliva sample for Drugs of Abuse Analysis 
(DOA), and answer questions about medicinal and non-medicinal substances 
ingested within the 12 hours preceding their participation. Subjects were then 
asked to complete the two psychometric tests; the Critical Tracking Task (CTT) 
and the Sustained Attention to Response Task (SART) (detailed descriptions of 
which can be found in Chapter 2, Section 2.4.1 and 2.4.2). Subjects could take 
part in the study once only, and were offered a bottle of water and a chocolate 
bar for their time and inconvenience.
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Breath alcohol readings were taken using the Lion Alcolmeter; model S-D (Lion 
Laboratories). Saliva samples were collected and analysed using the Cozart 
Rapiscan Instrument (Cozart Bioscience Ltd). The Cozart five panel test 
cartridges were chromatographic immunoassays that tested for the presence of: 
cannabinoids; amphetamines; cocaine; opiates and benzodiazepines.
4.3.2 Study Population
Subjects were recruited in two ways: they were either approached by 
researchers and asked if they were willing to take part; or the subjects selected 
themselves. One-hundred and sixty-three subjects satisfied the inclusion and 
exclusion criteria and were successfully recruited onto the study.
4.3.2.1 Inclusion Criteria
The inclusion criteria were as follows:
• Aged between 18 and 55 years inclusive
• Able and willing to provide written informed consent
4.3.2.2 Exclusion Criteria
The exclusion criteria were as follows:
• Any subject the investigator, or persons nominated by her, judged to be 
unsuitable
4.3.3 Study Procedure
Researchers set up a large tent inside the festivals with brightly coloured posters 
advertising the study. Upon completing the consenting process subjects were 
asked to refrain from drinking, smoking and eating until all the study procedures 
had been completed. Subjects were asked a series of questions prior to testing 
to establish their age, gender and consumption of prescription medications, over
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the counter medications, illegal drugs and/or alcohol during the previous 12 
hours. Following brief standardised instructions, the subjects completed the 
psychometric tests, (CTT and SART). After completion of the psychometric test 
battery which lasted approximately 10 minutes, subjects were required to take a 
breathalyser test and provide a saliva sample for Cozart Rapiscan Analysis. The 
saliva samples were taken back to the HPRU where they were stored in a 4°C 
fridge until analysis was carried out.
4.3.4 Statistical Methods
Performance was assessed using a one-way Analysis of Variance (ANOVA), 
Bonferoni adjusted for multiple comparisons. Statistical analysis software 
package SAS PC (Version 8, SAS Institute, CARY, NC, USA) was used to carry 
out the statistical analysis).
4.4 Results
4.4.1 Subject Demographics
One hundred and sixty-three subjects were recruited. One hundred and four 
subjects were male, and 59 were female. The age of subjects ranged from 18 to 
55 years inclusive (Mean= 27.98 yrs). Breath alcohol readings were converted 
into mg/100ml (mg %) using the blood: breath ratio of 2,300:1. Table 4.1 details 
basic subject demographics. Subject’s drug and alcohol use across three age 
bands is presented in Figure 4.1.
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Table 4.1 Subject demographics and other baseline characteristics of a 
field based study
Age
Gender BAC Illegal drug use
Male Female <80mg% >80mg%
Subjective 
(± alcohol)
Cozart 
(± alcohol)
18-22 36 20 43 2 7 2
23-30 35 22 38 0 7 8
31-55 33 17 36 3 3 6
A table detailing the number of subjects recruited at two music festivals. Subject demographics are split 
by age and gender. BAC denotes Blood Alcohol Concentration, mg/100ml (mg%). Subjective drugs 
refers to those subjects who reported drug use but produced a negative saliva sample on upon Cozart 
analysis.
In order to assess performance across the different conditions numerous drug 
groups were identified. For the purpose of this study, amphetamines and 
cocaine were combined into a “stimulants” group. Whilst it is acknowledged that 
this is a generic nomenclature, it was decided that the drug effects were similar 
enough to group them in this way. Where a subject had reported illegal drug use 
but was negative upon Cozart analysis they were assigned to a “subjective” 
group. Therefore, for initial analysis subjects were grouped in terms of whether 
they had consumed no drugs or alcohol, alcohol only, or a combination of illegal 
drugs and alcohol. Only subjects who had completed the test fully were included 
in the analysis The groups are presented in Table 4.2
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Table 4.2 Initial subject group classifications used for analysis based on 
positive Cozart analysis and breathalyser samples -  an illegal 
drugs field investigation
Group Number of subjects (n)
No drug and BAC = 0 37
No drugs and BAC <80mg% 68
No drugs and BAC >80mg% 4
Subjective report of drugs and BAC <80mg% 13
Subjective report of drugs and BAC >80mg% 5
+ve Cozart for stimulants and BAC <80mg% 2
+ve Cozart for stimulants and BAC >80mg% 3
+ve Cozart for cannabinoids and BAC <80mg% 4
+ve Cozart for cannabinoids and BAC >80mg% 3
+ve Cozart for polydrugs 5
A table detailing the different subject groups that were identified for analysis. The subjective drug 
groups had reported drug use but produced a negative saliva sample. +ve Cozart groups had 
produced a positive sample.
Fig
ur
e 
4.1
 
Di
sp
er
si
on
 
of 
dru
g 
us
e 
fro
m 
a 
sa
m
pl
e 
of 
su
bj
ec
ts
 
at
te
nd
in
g 
mu
sic
 
fe
st
iva
ls 
in 
su
m
m
er
 2
00
3
"0 °
43 O  
0 CO
+3 00 43 00
■ £ 0  ID O  10 O  IX) O
§ CO CM (N t-  r -
z
Dr
ug
 
an
al
ys
is
 
wa
s 
ca
rri
ed
 
ou
t 
us
ing
 
Co
za
rt 
Ra
pi
sc
an
 
(F
ive
 
Dr
ug
 
Pa
ne
l 
Co
za
rt 
Bi
os
ci
en
ce
 
Lt
d)
. 
Br
ea
th
al
ys
er
s 
we
re
 
ca
rri
ed
 
ou
t 
us
ing
 
the
 
Lio
n 
Al
co
m
et
er
 
S-D
 
(L
io
n 
La
bo
ra
to
rie
s)
. 
Th
e 
fie
ld 
co
nt
ro
l 
gr
ou
p 
co
m
pr
is
ed
 
of 
su
bj
ec
ts
 
wh
o 
ha
d 
co
ns
um
ed
 
no 
dr
ug
s 
or 
al
co
ho
l. 
Th
e 
no 
dr
ug
 
& 
<8
0m
g%
 
gr
ou
p 
ha
d 
co
ns
um
ed
 
no 
ill
eg
al
 d
ru
gs
 
an
d 
w
er
e 
be
low
 
80
mg
% 
(th
e 
UK
 
dr
ink
 
dr
ive
 
lim
it)
. 
Th
e 
su
bj
ec
tiv
e 
dr
ug
 
gr
ou
ps
 
ha
d 
re
po
rte
d 
dr
ug
 
us
e 
bu
t 
ha
d 
pr
od
uc
ed
 
a 
ne
ga
tiv
e 
sa
liv
a 
sa
m
pl
e 
up
on
 
Co
za
rt 
an
al
ys
is
. 
Th
e 
st
im
ul
an
ts
 
gr
ou
ps
 
we
re
 
po
sit
ive
 
for
 e
ith
er
 a
m
ph
et
am
in
e 
or 
co
ca
in
e.
 T
he
 
po
ly-
dr
ug
 
gr
ou
p 
wa
s 
po
sit
ive
 
for
 m
or
e 
tha
n 
on
e 
dru
g 
an
d 
al
co
ho
l 
at 
va
ry
in
g 
do
se
s.
4.4.2 Critical Tracking Task (CTT)
Data for mean reaction time to the peripheral stimuli is presented in Table 4.3. 
Subjects who subjectively reported drug use, and had consumed an amount of 
alcohol below the legal limit took significantly longer to respond to the peripheral 
stimulus than the control group. Those who were positive for cannabis use in 
combination with an amount of alcohol above the legal limit, and the poly-drug 
users also displayed significantly prolonged reaction times. When the drug using 
groups were combined to form two distinct groups a pattern of performance was 
seen. Performance of the drug using group below the legal limit approached 
significance (P = 0.0605). Mean reaction time for the drug using group who had 
consumed amounts of alcohol above the legal limit was also significantly 
impaired. Mean tracking deviation following response to peripheral stimuli 
(Table 4.4) was only able to demonstrate the impaired performance of subjects 
who had reported consuming illegal drugs and had levels of alcohol above the 
legal limit (once again this was with subjects who believed themselves to be on 
drugs but had provided a negative saliva sample). Impaired tracking deviation of 
the poly-drug using group approached significance (P = 0.0591). However when 
the drug using groups were combined tracking deviation was significantly 
impaired only for the group who had consumed alcohol in excess of the legal 
limit (>80mg%).
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Table 4.3 The effect of alcohol and illegal drug use on mean reaction
time assessed using the CTT
Drug Group n Mean SE SD Min Max Range Median
P
value
Control 37 570 32 196 339 1493 1154 515 -
No drugs <80mg% 68 578 15 127 404 1180 775 557 0.83
No drugs >80mg% 4 604 28 56 552 660 108 602 0.71
Subjective drugs 
<80mg% 13 685 53 189 526 1139 613 624 0.04
Subjective drugs 
>80mg% 5 609 20 45 557 653 96 621 0.63
Stimulants
<80mg% 2 547 201 284 346 748 401 547 0.85
Stimulants
>80mg% 3 759 115 198 558 955 397 765 0.07
Cannabis <80mg% 4 719 90 179 563 969 407 672 0.10
Cannabis >80mg% 3 811 53 93 756 918 162 759 0.02
Poly-drug 5 1023 119 422 588 1625 1038 907 <.0001
Drugs <80mg% 21 684 41 188 346 1139 793 624 0.06
Drugs >80mg% 14 813 81 303 557 1625 1068 742 <.0001
Mean reaction time to a peripheral stimuli using the Critical Tracking Task (CTT), (ms). Subjects were 
firstly divided according to their illegal drug and/or alcohol use. Following this drug users were divided 
according to whether they had consumed levels of alcohol above or below the legal limit. ANOVA was 
carried out on the individual groups and then on the two combined drug using groups,
P values are presented. n=number of subjects per group. SE=Standard Error, SD= Standard Deviation.
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Table 4.4 The effect of alcohol and illegal drug use on mean tracking
deviation assessed using the CTT
Drug Group n Mean SE SD Min Max Range Median
P
value
Control 37 45.7 3.4 20.6 22.0 117.5 95.5 38.9 -
No drugs <80mg% 68 44.7 2.8 22.8 15.2 162.4 147.2 39.5 0.83
No drugs >80mg% 4 99.9 9.1 18.2 43.0 85.6 42.6 69.6 0.08
Subjective drugs 
<80mg% 13 43.5 4.6 17.5 19.3 85.6 66.4 44.1 0.77
Subjective drugs 
>80mg% 5 72.6 18.1 40.4 24.1 135.9 111.9 64.9 0.01
Stimulants
<80mg% 2 58.3 26.5 37.4 31.8 84.7 52.9 58.3 0.45
Stimulants
>80mg% 3 50.5 7.0 12.2 42.1 64.5 22.4 44.8 0.72
Cannabis <80mg% 4 47.5 10.8 21.6 25.4 69.4 44.0 47.5 0.88
Cannabis >80mg% 3 44.0 3.3 5.8 37.3 48.0 10.6 46.6 0.90
Poly-drug 5 66.3 15.5 34.6 33.6 118.5 84.9 58.9 0.06
Drugs <8Omg% 21 46.2 4.1 18.8 19.3 85.6 66.4 44.1 0.93
Drugs >80mg% 14 62.8 8.5 31.9 34.1 136.0 111.9 55.4 0.02
Mean tracking deviation following response to a peripheral stimulus using the Critical Tracking Task 
(CTT), (pixels). Subjects were firstly divided according to their illegal drug and/or alcohol use. Following 
this drug users were divided according to whether they had consumed levels of alcohol above or below 
the legal limit. ANOVA was carried out on the individual groups and then on the two combined 
drug/alcohol groups, P values are presented. n=number of subjects per group. SE=Standard Error, 
SD= Standard Deviation
4.4.3 Sustained Attention to Response Task (SART)
In this study performance on the SART was not significantly effected by alcohol 
intake alone. Performance was significantly impaired for subjects who had 
consumed a combination of illegal drugs and alcohol, both above and below the 
legal limit. Those who reported drug use (but provided a negative saliva sample) 
and the cannabis users who had consumed lower levels of alcohol (<80mg%) 
responded incorrectly significantly more times than the control group. For those 
subjects who had consumed higher levels of alcohol (>80mg%) it was those who 
had also taken stimulants and cannabis who were significantly affected. When 
the drug users were combined into two groups both groups displayed 
significantly impaired performance in comparison to placebo. It is interesting to 
note that although performance of the Drug<80mg% and Drug>80mg% were
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significantly impaired in comparison to the control group, performance between 
the two drug groups was not significantly different (P = 0.45).
Table 4.5 The effect of alcohol and illegal drug use on sustained attention 
assessed using the SART
Drug Group n Mean SE SD Min Max Range Median
P
value
Control 39 8 1 4 0 16 16 6 -
No drugs <80mg% 68 9 1 5 0 20 20 8 0.36
No drugs >80mg% 4 6 2 5 2 12 10 5 0.52
Subjective drugs 
<80mg% 10 11 2 6 3 27 24 11 0.02
Subjective drugs 
>80mg% 5 12 3 6 6 22 16 11 0.11
Stimulants <80mg% 1 10 10 10 0 10 0.65
Stimulants >80mg% 3 15 6 10 5 25 20 15 0.02
Cannabis <80mg% 4 13 2 4 11 19 8 11 0.05
Cannabis >80mg% 2 15 11 8 23 15 15 0.03
Poly-drug 4 10 2 4 7 16 9 9 0.34
Drugs <80mg% 17 12 1 5 3 27 24 11 <0.001
Drugs >80mg% 12 13 2 7 5 25 20 11 <0.001
Number of incorrect presses during the Sustained Attention to Response Task (SART). Subjects were 
firstly divided according to their illegal drug and/or alcohol use. Following this drug users were divided 
according to whether they had consumed levels of alcohol above or below the legal limit. All figures 
presented represent incorrect responses to the no-go symbol. ANOVA was carried out on the 
individual groups and then on the two combined drug/alcohol groups, P values are presented. 
n=number of subjects per group. SE=Standard Error, SD= Standard Deviation.
4.4.4 Discriminant Analysis
Upon closer examination of the CTT data test variables were refined to select 
the most discriminating sections of the tracking task (analysis not presented). 
During the study phase it was noted by researchers that whilst subjects in the 
field control group tracked the target object smoothly throughout the duration of 
the task there were distinct differences in certain other groups. These 
observations were investigated post database lock, Figure 4.2 displays the 
tracking variance across the whole task of the drug groups. It is interesting to 
note that performance of the control group was fairly consistent, minimum 
tracking variance in this group was 125.16 pixels and maximum tracking
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variance was 278.67 pixels. This is in comparison to the wide variance scores 
of the drug groups. Tracking variance was one of the response measures 
selected to be used as a discriminating performance variable. Other response 
measures selected as most the discriminating variable were mean tracking 
deviation after a subject had responded to a peripheral stimulus ([section 1- 
3+10-12] Figure 4.3), mean tracking deviation (Figure 4.4), and mean reaction 
time ([sections 1-8] Figure 4.5). These response measures were combined with 
number of incorrect presses derived from the SART task (Figure 4.6).
Data from the response measures discussed above, combined with age and 
gender were again subjected to a discriminant analysis in order to determine if it 
was possible to categorise the subjects into different drug and alcohol groups 
based solely on their performance of the psychometric tests. Results from the 
discrimination procedure are outlined in Table 4.6. Based on their test 
performance, 22% of the control group (n=8) were correctly identified by the 
analyses. The majority of the control group (n=27) were placed in the non drug 
using <80mg% group. Although technically the wrong classification, these 
subjects were correctly assigned to a “legal” group (a group that would not be 
arrested at the roadside), in other words at the roadside, they would have 
committed no offence. The same can be seen when the discriminant analyses 
assigned the performance of the no drugs <80mg% group, 94 % (n=64) were 
correctly assigned to the legal group. However, 50% of subjects who had 
consumed alcohol in excess of the legal limit were correctly placed in the 
appropriate group, 50% were also placed in a legal group (no drugs, <80mg%). 
The numbers that are involved in this group are small (n=4), and it is possible 
that the 2 subjects who were incorrectly placed (in the <80mg% group), were 
only slightly over the legal drink drive limit, therefore based on their test
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performance they were categorised as performing in a similar manner to 
unimpaired subjects. Of subjects who had consumed illegal drugs and 
<80mg%, only 18% (n=3) were correctly placed, the majority of subjects (n=13) 
were placed in the no drugs <80mg% group. For the group of subjects who had 
consumed illegal drugs in combination with >80mg% 18% (n=2) were correctly 
identified, based on test performance, 9 subjects from that group were 
categorised as belonging to the no drugs <80mg% group. In summary, from the 
subjects entered into the discriminant analysis model, it was possible to correctly 
identify 99 out of 105 subjects who had consumed no illegal drugs, and were 
below the UK legal limit for alcohol. Two out of 4 subjects who had consumed 
levels of alcohol in excess of the legal limit, but no illegal drugs, were correctly 
identified. This provides the first stage of evidence that it is possible to 
retrospectively assess performance, and based on a subjects score; predict 
whether or not they performing in a, manner which may be due to a drug.
Figure 4.2 The effect of illegal drug use on tracking variance assessed 
using the CTT
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A boxplot displaying the mean tracking variance of the two illegal drug groups in comparison to a 
control group. Control n = 37, Drugs <80mg% n = 21, Drugs >80mg% n = 14.
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Figure 4.3 The effect of illegal drug use on mean tracking deviation
following response to a peripheral stimulus assessed using
the CTT
W
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Drugs >80mg%
The effect that illegal drug use has on selected sections of mean tracking deviation following response 
to a peripheral stimuli (1-3+10-12) (±SEM). Subjects were divided according to their illegal drug and/or 
alcohol use. The control subjects had consumed no alcohol or drugs but were tested in the same 
environment as the other subjects. Control n = 37, Drugs <80mg% n = 21, Drugs >80mg% n = 14. 
**P<0.01. CTT = Critical Tracking Task.
Figure 4.4 The effect of illegal drug use on mean tracking deviation 
assessed using the CTT
50
w 45
a> 25
Control Drugs <80mg% 
Drug group
Drugs >80mg%
The effect that illegal drug use has on mean tracking deviation (±SEM). Subjects were divided 
according to their illegal drug and/or alcohol use. The control subjects had consumed no alcohol or 
drugs but were tested in the same environment as the other subjects. Control n = 37, Drugs <80mg% 
n = 21, Drugs >80mg% n = 14. CTT = Critical Tracking Task.
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Figure 4.5 The effect of illegal drug use on mean reaction time to a
peripheral stimulus assessed using the CTT
1200
1000
wT
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Control Drugs <80mg% Drugs >80mg%
Drug group
The effect that illegal drug use has on selected sections of mean reaction time 1-8 (±SEM). Subjects 
were divided according to their illegal drug and/or alcohol use. The control subjects had consumed no 
alcohol or drugs but were tested in the same environment as the other subjects. Control n = 37, Drugs 
<80mg% n = 21, Drugs >80mg% n = 14. **P<0.01, ***P<0.001. CTT = Critical Tracking Task.
Figure 4.6 The effect of illegal drug use on subjects ability to sustain 
their attention assessed using the SART
* * *
Control Drugs <80mg% Drugs >80mg%
Drug group
The effect that illegal drug use has on the SART. Subjects were divided according to their illegal drug 
and/or alcohol use. The control subjects had consumed no alcohol or drugs but were tested in the 
same environment as the other subjects. Control n = 37, Drugs <80mg% n = 21, Drugs >80mg% n = 
1 4  **p<o.o i, ***P<0.001. SART = Sustained Attention to Response Task.
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Table 4.6 The ability to categorise subjects based on test performance. 
Discriminant analyses of response measures based on a combination of 
the CTT and SART
Drug Group Control No drugs <80mg%
No drugs 
>80mg% Drugs <80mg%
Drugs
>80mg%
Control 22% (8) 73% (27) 3% (1) 3% (1) -
No drugs 
<80mg% 19% (13)
75% (51)
3% (2) 1%(1) 1%(1)
No drugs 
>80mg% _
50% (2)
50% (2)
Drugs <80mg% 6% (1) 76% (13) - 18% (3) -
Drugs >80mg% - 82% (9) - - 18% (2)
A table detailing the results of a discriminant analysis based on data collected in the field. Figures 
represent the percentage of subjects that were assigned to each drug group based on test 
performance. CTT = Critical Tracking Task, SART = Sustained Attention to Response Task, (n = 
appears in parenthesis)
4.5 Discussion
Psychometric tests have consistently been shown to be reliable and valid 
measures of human performance (Wetherall, 1996; Moskowitz and Fiorentino, 
2000). The skills related to car driving that are most sensitive and frequently 
used to assess performance are reaction time and tracking tasks (Patat, 1998). 
However, the aim of this study was to assess the performance of a large sample 
of subjects in field conditions, which is not typical of the use of psychometrics 
within psychopharmacology, demonstrated by the fact that there is no peer 
reviewed work to relate this aspect of the results to. These subjects had 
consumed various combinations of alcohol and illegal drugs. The study was 
largely uncontrolled in that assessments were made at different times of day and 
in different light conditions mimicking use at the roadside. Despite lack of 
information on precise doses of illegal drugs taken, time of ingestion etc., the 
results of the study demonstrate a clear and significant difference between 
participants who had consumed neither drugs nor alcohol and those that had (or 
reported that they had) consumed an illegal drug and alcohol. Performance on
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both the CTT and SART were sensitive to drug consumption, and in general,
performance was further exacerbated by alcohol.
Subjects who had consumed alcohol, illegal drugs or a combination of both 
found it more difficult to divide their attention, and to maintain performance on a 
primary task whilst responding to an unexpected event. Subjects in this study 
were positive for either, or a combination of, cannabis, alcohol and stimulants. 
As already identified in the literature review the impairing effects of these drugs 
are not yet categorically proven, nor is the impact of mixing these drugs together 
been fully documented. Cannabis has been shown to have both a negative 
impact of performance (Ramaekers et al., 2000; Chait and Perry, 1994; 
Papafotiou et al., 2005a; 2005b; Kurzthaler et al., 1999) and a neutral effect 
(Lamers and Ramaekers, 2001; Pickworth et al., 1997; Liguori et al., 2002. 
There is also inconsistency when it comes to the reporting of the effects of the 
stimulants on performance. Some studies failed to show significant results 
(Stillman et al., 1993; Farre et al., 1993; Hooper at al., 2004, Fillmore et al., 
2002; Vollenweider et al., 1998), few demonstrated impairment (Parrott and 
Lasky, 1998) with some studies even demonstrating a slight improvement in 
performance (Ramaekers and Kypers, 2006; Lamers et al., 2003). However, 
when these drugs were combined with varying levels of alcohol published 
literature is still inconclusive (Liguori et al., 2002; Foltin et al., 1993; Higgins et 
al., 1993; Robbe, 1998; Farre et al., 1993). It has been suggested that tracking 
accuracy is a good indicator of road tracking ability as this skill operates outside 
of conscious control, and as such is controlled by the automatic information 
processing system (Smiley, 1986). Subjects also found it significantly more 
challenging to maintain their attention to periodically occurring events (sustained 
attention). In addition subjects who had consumed alcohol, illegal drugs or a
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combination of both found it significantly more difficult to attend to a monotonous 
task, experiencing more attentional failures, and action slips (Manly et al., 1999). 
Of specific relevance, both the CTT and the SART were able to significantly 
demonstrate impairment of a drugged subject’s performance in comparison to a 
control. In particular, subjects that under present legislation could not be 
apprehended at the roadside, could now be detained as the test battery would 
offer an indication that although below the legal drink drive limit they were 
behaving in an impaired manner which may jeopardise their ability to drive 
safely.
The secondary aim of this study was to assess the possibility of retrospective 
determination of drug use, whether it is possible when no other information is 
available, to predict whether an individual had consumed impairing psychoactive 
drugs based solely on their performance of psychometric tests. This study 
indicated that it was possible to group together the performance of subjects who 
are impaired due to a combination of many psychoactive substances; this is 
despite the different modes of action on the Central Nervous System (CNS). 
Seventy eight percent of the subjects sampled were correctly assigned based on 
their performance on the CTT and SART. These results, although promising 
were derived from a very small self-selected sample. It is probable that the 
individuals that had consumed a large amount of illegal drugs or who were 
experiencing excessive debilitating effects of the drugs they had consumed may 
not have identified themselves for the study. The next stage in development of 
the impairment device must concentrate on much larger samples of drug users, 
both those that “experiment” or are recreational users, and those that have 
dependency issues. The combination of more of this type of data, with the 
collection of further normative values from subjects who have consumed no
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drugs or alcohol will continue to test the strength of the discriminant analysis,
and the possible subsequent production of an objective “pass” or “fail” criteria
which can be used at the roadside.
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CHAPTER 5
IMPAIRMENT ASSESSMENT OF A COHORT OF DRUG DEPENDENT 
SUBJECTS
5.1 Introduction
As well as the recreational drug users that can reasonably be expected to be 
represented amongst road users, those with classified drug use problems will 
also be represented amongst drivers. The Driver and Vehicle Licensing Agency 
(DVLA) stipulate that it is a legal requirement of all drivers to ensure they are fit 
to drive. It follows therefore that it is the responsibility of the illegal drug user to 
inform the DVLA that they are currently experiencing drug 
dependency/addiction, or that they experienced these problems in the past. 
These drivers would then be required to complete a medical questionnaire, and 
grant the DVLA permission to contact their doctors. The DVLA would then 
usually request a further medical and a urine test. If the drug user meets the 
DVLA requirements at the time of assessment, they are permitted to retain their 
licence. If the driver fails to meet the criteria they can have their licence revoked 
and are advised when they are permitted to re-apply. Although this process 
seems robust and transparent it relies on the drug users identifying themselves 
in the first place. In the circumstance where the illegal drug user has been 
involved in a road traffic accident, the police will send the DVLA an incident 
report resulting in the drug user being investigated. There is an assumption 
therefore that although drug dependency is recognised by the DVLA as having 
the capacity to affect an individuals driving, it is not compulsory for drug 
addicts/dependents to undergo driving assessment in order to keep their licence 
whilst in treatment.
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At present in the UK, the Field Impairment Test (FIT) is the only method 
available to the police for use at the roadside to screen drivers for drug induced 
driving impairment. The FIT is a collection of subjectively assessed tasks 
designed to assess the psychomotor and cognitive functioning of an individual 
(Silber et al., 2005). Use of the FIT in the UK is based on elements of the 
Standardised Field Sobriety Test (SFST) battery used in America, specifically 
developed to test for alcohol intoxication in the field (Burns and Moskowitz, 
1977). The use of the SFST to assess drug induced impairment was followed 
by the introduction of the Drug Evaluation and Classification Program (DECP), in 
which US officers took part in an intensive training program resulting in them 
qualifying as Drug Recognition Experts (DREs), (Schechtman and Shinar,
2005). The DECP program forms a twelve step process during which the 
suspect’s drug use and impairment levels are identified (Schechtman and 
Shinar, 2005). This process encompasses a structured interview, behavioural 
assessments (the SFST), and a medical examination. In 1997, elements of the 
drug evaluation system used in the US were introduced into UK officer training, 
These elements included: the FIT; and drug recognition training (Stark et al.,
2002). Those who advocate use of the FIT in the UK (Collier, 2001) argue that 
the process is a systematic and standardised method of examining a subject to 
determine whether or not they are impaired. A trained officer will never reach a 
conclusion based on one element of the examination, but instead, on the totality 
of the facts that emerge. Collier (2001), goes on to argue that the process is 
standardised in that it is conducted in exactly the same way, by every trained 
officer, for every suspect, and that trained officers are prohibited from leaving out 
or modifying any step of the evaluation process.
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Of the five tests (Pupillary Examination, Romberg Balance Test, Walk and Turn 
Test, One Leg Stand Test, and Finger to Nose Test), two of the tests (Walk and 
Turn and One Leg Stand) have been validated. Burns and Moskowitz (1977), 
demonstrated that it was possible to distinguish between impaired and non­
impaired subjects in 83% of cases. A follow up study (Tharp et al., 1981) 
demonstrated that officers were able to distinguish between impaired and non 
impaired performance in 82% of cases using the Walk and Turn Test, and in 
65% of cases using the One Leg Stand Test. The subjectivity of the FIT has 
attracted substantial criticism (Cole and Nowaczyk, 1994; O'Keefe, 2001), and 
issues of validity have been raised (Heishman et al., 1998). Only a small number 
of validation studies have been published in peer reviewed journals, and these 
have focused on alcohol not illegal drugs (Cole and Nowaczyk, 1994; Heishman 
et al., 1998; McKnight et al., 2002; Stuster, 2006). Studies that have focused on 
illegal drug use have concentrated on the 12 step Drug Evaluation and 
Classification Program (DECP) that is in use in the US (Bigelow et al., 1985; 
Compton, 1986; Heishman et al., 1998), not just the SFSTs in isolation. Until 
2005, no specific research had been published which attempted to assess 
whether the impairment tests when used in isolation, were sensitive measures of 
performance following the consumption of a drug, other than alcohol. In order to 
rectify this Papafotiou et al., (2005a) assessed subjects performance on the 
SFSTs following doses of Tetrahydrocannabinol (THC). They concluded that 
the impairment tests were a moderate predictor of impairment (Papafotiou et al., 
2005a; 2005b). Conversely, Silber et al., (2005) concluded that the SFSTs were 
not an efficient method of detecting impairment when subjects were dosed with 
amphetamine. It is due to the ambiguity of the SFST, and FIT, that an objective,
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standardised battery of psychometric tests, which have proven sensitivity, would 
offer a useful screening method for police officers at the roadside.
The statutory offences relative to drug-induced driving impairment are contained 
within Section 3a and 4 of the Road Traffic Act 1988 (as amended by Section 3 
and 4 of the Road Traffic Act 1991), and Section 6 of the Road Traffic Act 1998 
(as amended by Section 107 and Schedule 7 Railways and Transport Safety Act
2003). At the heart of prosecutions for driving whilst unfit through drink or drugs 
remains the requirement to provide evidence that the person is unfit to drive. 
Although a chemical based roadside test would confirm the presence of an 
illegal drug, this would only confirm drug use, not provide evidence that the 
driver was impaired, and therefore unfit, due to that drug. The law change in 
2003 gave officers the authority to require a subject to perform preliminary 
impairment tests at the roadside. Refusal to perform these tests would result in 
the subject being arrested; unsatisfactory performance on the preliminary tests 
would also result in arrest.
The development of a documented standardised procedure for carrying out the 
FIT came in 1998 (Stuster and Burns, 1998). However, with only two of the five 
tests in the FIT being validated (Burns and Moskowitz, 1977), and this validation 
being with alcohol, quite how the tests relate to driving ability, and their efficacy 
in detecting impairment due to illegal drug use is unknown, and yet to be proven. 
This study investigated the performance of a cohort of drug dependent subjects 
using both the FIT and a portable psychometric device.
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5.2 Study Aims
The aims of this study were:
• To assess the psychomotor performance of a cohort of drug dependent 
users compared to a drug free matched control group
• To develop the model for determining retrospective drug use based on 
test performance and simple demographic data
• To assess the sensitivity of the FIT to the effects of drug use on a cohort 
of drug dependent subjects compared to a control group
• To assess the combined sensitivity of psychometric assessment and the 
FIT
5.3 Methodology
5.3.1 Study Design
A total of 60 (30 ACORN, 30 control) subjects who fulfilled the entry criteria and 
had provided written informed consent were enrolled onto the study. Subjects 
were required to take an alcohol breath test, provide an oral fluid sample for a 
drugs of abuse screen, and complete a questionnaire. Subjects were also 
required to complete two psychometric tests: Critical Tracking Task (CTT) and 
Sustained Attention to Response Task (SART). Following completion of the 
tests, subject’s performance was assessed using the Field Impairment Test 
(FIT). Subjects took part in only one assessment day each, where study 
procedures took approximately 2 hours to complete. Upon completion of study 
procedures subjects were discharged from the unit and were transported home 
by taxi. This study was approved by an independent ethics committee (South 
West Surrey Ethics Committee) and all subjects were given £30 compensation.
-107-
5.3.2 Study Population
Thirty subjects were recruited via a local drug rehabilitation centre (ACORN 
services). Subjects were required to volunteer themselves and assured that 
participation in the trial would not advantage or disadvantage their treatment. 
Each subject was collected by taxi from a pre arranged destination, and upon 
arrival were assessed as to whether they were capable of providing informed 
consent. A further 30 control subjects were also recruited, matched to the drug 
using group by age and gender. These subjects were recruited using the HPRU 
subject database. As an added screening procedure the control subjects were 
required to provide a urine sample for a drugs of abuse screen, to ensure that 
they were drug free and therefore true controls to the drug users.
5.3.2.1 Inclusion Criteria
The inclusion criteria were as follows:
• Male or female aged between 18 and 65 years inclusive
• Able and willing to give written informed consent
• Either enrolled as a client at ACORN services to be included in the drug 
group
• Or, age and gender matched to a member of the drug group, and 
providing a negative drugs of abuse test during screening
5.3.2.2 Exclusion Criteria
The exclusion criteria were as follows:
• Any subject that the investigator judged unsuitable (e.g. if subject was 
clearly in a state where informed consent would be compromised)
• Any control subject who provided a positive drugs of abuse urine test 
during screening
• Any control subject who provided a positive alcohol breath test
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5.4 Study Procedures
Upon completing the consenting and screening processes all 60 subjects were 
required to provide an oral fluid sample for drugs of abuse analysis. The oral 
fluid samples were collected using a sterile Salivette collection device and 
underwent primary screening analysis using surface enhanced raman 
spectroscopy. Further confirmatory analysis was carried out at an independent 
external analytical laboratory. The saliva samples were tested for; amitriptyline, 
amphetamine, benzoylecgonine, buprenorphine, codeine, diazepam, dothiepin, 
methadone metabolite (EDDP), 3,4-Methylenedioxyamphetamine (MDA), 3,4- 
methylenedioxy-A/-ethylamphetamine (MDEA), 3,4-methylenedioxy-N- 
methylamphetamine (MDMA), morphine, oxazepam, Tetrahydrocannabinol 
(THC), desmethyldiazepam, mirtazapine, pethidine, caffeine, 6- 
monoacetylmorphine, dihydrocodeine, methadone, norbuprenorphine, cocaine, 
cocaethylene, methamphetamine, oxazepam, temazepam, nortriptyline, 
propoxyphene, and venlafaxine. Breath alcohol readings were taken using the 
Lion Alcolmeter: model S-D (Lion Laboratories).
5.4.1 Questionnaire
All 60 subjects were asked questions regarding any medications or drugs they 
had consumed in the days preceding participation in the study. The questions 
asked of the ACORN subjects differed slightly from those asked of the control 
group. A vast amount of epidemiological data was collected from the 
questionnaires and although interesting to the field of drug use and drug 
intervention programs, is outside of the realm of this thesis. However, in order
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that this study can be replicated in its entirety the questionnaires administered to 
both groups are presented below.
5.4.1.1 A CORN Questionnaire
The ACORN subjects were asked the following questions;
• How long have you been attending ACORN?
• How often do you go to ACORN?
• Have you been prescribed any medication as a consequence of attending 
ACORN?
• How long have you been taking the medication?
• How often do you take the medication?
• When was the last time you took your medication?
• Have you been prescribed any medication from your GP?
• If so, how long have you been taking the medication, how often do you
take it, and when was the last time you took it?
• Are you taking any other medication, such as that bought at a chemist or 
herbalist?
• If so, how long have you been taking the medication, how often do you
take it, and when was the last time you took it?
• Have you taken any illegal substances recently?
• When was the last time you took it?
• How often do you take it?
• Do you drink alcohol?
• When was the last time you drank any alcohol?
• Do you smoke?
• How many cigarettes do you smoke per day?
5.4.1.2 Control Group Questionnaire
• Have you been prescribed any medication from your GP?
• How long have you been taking the medication?
• How often do you take the medication?
• When was the last time you took your medication?
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• Are you taking any other medication, such as that bought at a chemist or 
herbalist?
• If so, how long have you been taking the medication, and how often do 
you take it?
• Do you drink alcohol?
• When was the last time you drank any alcohol?
• Do you smoke?
• How many cigarettes do you smoke per day?
5.4.2 Psychometric Assessments
Following completion of the questionnaire all 60 subjects were required to carry 
out two psychometric tests (CTT and SART) which lasted approximately 10 
minutes. Detailed description of the tests used can be found in Chapter 2 
(Sections 2.4.1 and 2.4.2).
5.4.3 The Field Impairment Test (FIT)
The FIT procedure replicated exactly the testing that would be carried out by a 
police officer at the roadside. All test descriptions and procedures were carried 
out in accordance with: “The National Drug Recognition Training, Drug Influence 
Recognition and Field Impairment Testing -  Instructors Manual” (Copyrighted to 
the Home Office 2001, Version 2, published by Northamptonshire Police, 
September 2001). All of the FIT tests in this study were carried out by FIT 
Instructors (those trained to a level by which they are permitted to train police 
officers in the procedures). Before each assessment began subjects were 
asked to list any medical conditions which they believed would hinder their 
performance on the tasks. Restrictions to the utility of the FIT (as identified in 
the Instructors Manual DRT Instructors Manual V2. 2001) include; subjects who 
are 65 years and older and those subjects who are 5 stone overweight. These
-111 -
subjects cannot be expected to carry out the tests. Also, subjects who have 
injuries to their legs, or inner ear disorders may have difficulty with the balance 
tests (DRT Instructors Manual V2. 2001).
5.4.3.1 Pupillary Examination
A standardised FIT pupilometer provided to police officers trained to carry out 
the FIT, was used to assess the size of the subject's pupils. The Instructor’s 
Manual (DRT Instructor’s Manual V2. 2001) documents that an unimpaired pupil 
size measures between 3.0mm and 6.5mm. Any readings outside this range 
should be recorded as abnormal. The exact measurement of each of the 
subject’s pupils was documented. If the pupil sizes were within the abnormal 
range then this should be taken into account when assessing the subjects 
performance on all the other tests that comprise the FIT. No further guidance as 
to the exact impact that this should have on the instructor’s overall impression of 
the subject is provided by the instructor’s manual or within instructor training.
5.4.3.2 Romberg Test
The Romberg Test is described in the instructor’s manual as an indicator of the 
subject’s internal clock and body sway, as certain drugs will either speed up or 
slow down the body clock and some drugs will cause the suspect to sway (DRT 
Instructors Manual V2. 2001). The subject was asked to tilt their head back 
slightly, close their eyes and estimate the elapse of 30 seconds. The Instructor’s 
Manual documents that results between 25 and 35 seconds are considered 
normal (DRT Instructors Manual V2. 2001). Two aspects of performance were 
assessed during this test, the subject’s ability to follow instructions, and their 
level of performance. Performance was judged in terms of whether the subject
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was able to follow instructions, and stand still with their feet together. They were 
also assessed on the presence of any body tremors, eyelid tremors, or body 
sway from front to back and/or side to side (DRT Instructors Manual V2. 2001). 
Lastly, the instructor’s manual requires that subjects were judged on the amount 
of time they had estimated. The test should be terminated if 90 seconds passes 
and the subject has not yet finished. The only further instruction the manual 
provides is that “some drugs speed up the subject’s internal body clock, so that 
subjects open their eyes after only 10-15 seconds. Other drugs may slow down 
the body’s internal clock so that the subject keeps their eyes closed for 60 
seconds or more.” (p 43, DRT Instructors Manual V2. 2001)
5A.3.3 Walk and Turn
The Walk and Turn Test is described as assessing the subject’s ability to divide 
their attention (between balance and information processing). The subject was 
required to take nine steps in one direction, turn round and take nine steps back 
whilst counting aloud. Subjects were assessed on their ability to listen to the 
instruction and eight separate performance indicators: balance; starts test before 
instructions were complete; stops walking at any time; steps off line; subject 
takes the wrong number of steps; subject fails to touch heel to toe; subject uses 
their arms to maintain balance; and lastly turns improperly. Due to the validation 
research that has been carried out using this test, the instructor’s manual states 
that if subjects displayed two or more of the performance indicators, it was likely 
that they were impaired, (DRT Instructors Manual V2. 2001). This should have 
an impact on the overall decision pertaining to the subject’s overall impairment, 
but once again no direction is provided as to how an exact decision can be 
reached.
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5.4.3.4 One Leg Stand
This required the subject to balance on one leg at a time whilst the other leg is 
raised a short distance off the ground (16-22cm), the subject was also required 
to simultaneously count aloud. This task is described within the Instructor’s 
Manual as a divided attention task during which the individual is assessed on 
their ability to follow instructions, counting, and balance (DRT Instructors Manual 
V2. 2001). Performance indicators for this test were: whether the subject drops 
their foot; uses their arms to balance; sways; or hops. As in the case of the 
Walk and Turn Test, due to the validation research that has been carried out 
using this test, the instructor’s manual states that if subjects displayed two or 
more of the performance indicators, it is likely that they were impaired, (DRT 
Instructors Manual V2. 2001). This should have an impact on the overall 
decision pertaining to the subject’s overall impairment, but once again no 
direction is provided as to how an exact decision can be reached.
5.4.3.5 Finger to Nose
The Finger to Nose Test is described as a test of co-ordination and depth 
perception (DRT Instructors Manual V2. 2001). It required the subject to touch 
the tip of their nose with the tip of their index finger. This was carried out with 
their head tilted back and eyes closed. Individuals were assessed on: ability to 
follow commands; whether they used the correct hand; and the amount of body 
sway. Once again no exact direction as to how to grade performance was 
provided.
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Presently, in normal operational circumstances, based on the totality of the 
subject’s performance on all of the tests, a value judgement pertaining to 
whether the individual is impaired is made. There is no provision of a pass or 
fail criterion against which a subject’s performance can be assessed. For the 
purpose of this study a forced choice element was introduced. At the end of 
each FIT test the instructors were required to decide whether the subject had 
passed or failed the FIT as a whole. Passing the test would mean that the 
subject did not display any significant signs of impairment. A subject must be 
classified as failing the FIT if, based on the instructor’s impressions the subject 
seemed impaired. If the FIT instructor’s could not reach a decision based on the 
subject’s performance then they were allowed to record an uncertain verdict.
5.5 Results
Sixty subjects were enrolled onto the study and completed all of the study 
procedures. Twenty six subjects were female (13 ACORN subjects, and 13 
control subjects), and 34 were male (17 ACORN subjects, and 17 control 
subjects). Mean age of the female subjects was 37 years; mean age of the male 
subjects was 33 years. Table 5.1 presents the saliva analysis results. Only 2 
subjects achieved a positive breathalyser test; both were ACORN subjects and 
both had a Blood Alcohol Concentration (BAC) below 50mg/100ml of blood. 
Data was analysed by separating the subjects into 4 subject groups as is 
presented in Table 5.2. Subjects were included in the illegal drug group if they 
tested positive for the following compounds: morphine; 6-monoacetylmorphine, 
codeine, dihydrocodeine, cocaine, benzoylecogonine, cocaethylene, 
methamphetamine, MDA, MDMA, MDEA, THC. Subjects who tested positive for 
more than one of the above were classified as poly-drug users. Subjects who
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tested positive for prescribed medications only were placed in the no illegal 
drugs group. Statistical analysis software package SAS PC (Version 8, SAS 
Institute, CARY, NC, USA) was used to carry out the statistical analysis). An 
analysis of variance (ANOVA) was used to assess statistical significance.
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Table 5.2 Drug groupings for analysis
Drug Group Number of Subjects
Control Group 30
No Illegal drugs <80mg% 6
Illegal drugs <80mg% 13
Poly-drug Group 11
This table details the numbers of subjects in each group based on their confirmed saliva analysis. 
Statistical analysis was carried out based on these groupings.
5.5.1 Critical Tracking Task (CTT)
The response measures identified as being most discriminating to the effects of 
illegal drug use were analysed. Detailed description of these can be found in 
Chapter 4 (Section 4.4.4). Data for mean tracking deviation (Table 5.3) showed 
no significant differences across the three drug groups or in comparison to the 
control group (P=0.79). In fact the control group exhibited the highest tracking 
deviation however, this could be due to the control group having the largest 
sample size (n=29). Mean tracking deviation assessed immediately following 
response to the peripheral stimuli (Table 5.4) did not produce a significant result 
(P=0.12). However, looking at the comparisons performance of the poly-drug 
group did approach significance (P=0.07), and a trend towards a decrement in 
performance can be seen in the illegal drug group in comparison to the control 
and no drug group. It is also interesting to note that the maximum tracking 
deviation of the two illegal drug groups (drugs <80mg% and ploy-drug group) 
were elevated in comparison to the non drug using groups (111 and 110 pixels 
respectively) but this did not reach significance. No significant performance 
decrement was identified for the reaction time response measure either (P= 
0.68, Table 5.5).
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Table 5.3 The performance of drug dependent subjects on a motor
task: mean tracking deviation
Drug Group n Mean SD SE Min Max Median
P
value
Control 29 34.2 14.6 2.7 23.3 92.6 28.63 -
No drugs <80mg% 6 29.3 6.0 2.5 22.3 37.2 29.6 0.72
Drugs <80mg% 13 32.2 8.1 2.3 22.4 50.7 30.5 0.93
Poly-drug 11 32.1 7.6 2.3 22.3 45.9 29.5 0.93
Mean tracking deviation (in pixels) assessed using the Critical Tracking Task (CTT). Subjects were 
divided based on their confirmed saliva analysis. An ANOVA and Dunnetts test was used for pairwise 
comparisons, P values are presented, n = number of subjects per group. SE=Standard Error, SD= 
Standard Deviation. Min=Minimum, Max=Maximum.
Table 5.4 The performance of drug dependent subjects on a motor 
task: mean tracking deviation following response to a
peripheral stimulus
Drug Group n Mean SD SE Min Max Median
P
value
Control 29 42.5 14.7 2.7 24.9 82.5 39.4
No drugs <80mg% 6 46.0 14.8 6.0 32.4 70.6 40.4 0.96
Drugs <80mg% 13 51.5 25.2 7.0 17.8 110.5 48.1 0.40
Poly-drug 11 58.3 23.6 7.1 25.8 109.5 52.1 0.07
Mean tracking deviation (in pixels) following response to a peripheral stimulus (1-3+10-12) assessed 
using the Critical Tracking Task (CTT). Subjects were divided based on their confirmed saliva 
analysis. An ANOVA and Dunnetts test was used for pairwise comparisons, P values are presented, n 
= number of subjects per group. SE=Standard Error, SD= Standard Deviation. Min=Minimum, 
Max=Maximum.
Table 5.5 The performance of drug dependent subjects on a motor
task: mean reaction time
Drug Group n Mean SD SE Min Max Median
P
value
Control 29 593 189 35 378 1367 539 -
No drugs <80mg% 6 587 81 33 529 743 549 1.00
Drugs <80mg% 13 609 150 42 395 901 571 1.00
Poly-drug 11 529 164 49 267 845 533 0.63
Mean reaction time sections 1-8 (ms) assessed using the Critical Tracking Task (CTT). Subjects were 
divided based on their confirmed saliva analysis. An ANOVA and Dunnetts test was used for pairwise 
comparisons, P values are presented, n = number of subjects per group. SE=Standard Error, SD= 
Standard Deviation. Min=Minimum, Max=Maximum.
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5.5.2 Sustained Attention to Response Task (SART)
In this study no significant differences were identified on the SART between the 
drug dependent subjects and the control group (P=0.49). Drug dependent 
subjects who tested negative for illegal drug use and those who tested positive 
for 1 drug or poly-drug use performed in the same manner as the control 
sample. Data is presented in Table 5.6
Table 5.6 The performance of drug dependent subjects on a sustained 
attention task
Drug Group n Mean SD SE Min Max Median
P
value
Control 30 5 4 0.6 1 14 4 -
No drugs <80mg% 6 5 2 0.7 4 8 5 1.00
Drugs <80mg% 13 7 4 1 2 14 7 0.38
Poly-drug 11 5 5 1 0 14 3 1.00
Mean incorrect responses assessed using the Sustained Attention Task (SART). Subjects were 
divided based on their confirmed saliva analysis. An ANOVA and Dunnetts test was used for pairwise 
comparisons, P values are presented, n = number of subjects per group. SE=Standard Error, SD= 
Standard Deviation. Min=Minimum, Max=Maximum.
5.5.3 Field Impairment Test (FIT)
The dispersion of subjects who passed and failed the FIT test is presented in 
Table 5.7. Of the 36 subjects who were unimpaired (negative drugs of abuse 
saliva sample), 24 were judged to have passed the FIT. Of 24 subjects who 
were under the influence of illegal drugs at the time of testing only 8 failed due to 
unsatisfactory performance (33%). Four of the study subjects were judged by 
the researchers to be unable to carry out the tests due to some form of physical 
injury or disability (7%).
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Table 5.7 The pass and fail rates of subjects enrolled in a drug study
assessed using the Field Impairment Test
Drug group
FIT results
Fail Pass Uncertain
Unable to carry out 
test
Control group 5 21 4 0
No illegal drugs <80mg% 1 3 1 1
Illegal drugs <80mg% 3 4 3 3
Poly-drug 5 3 3 0
This table displays the numbers of subjects who passed and failed the FIT test. Two researchers 
carried out each FIT test, if an agreement as to subject’s performance could not be reached the test 
result was classified as uncertain. Subjects could not carry out the test if they were experiencing some 
form of physical injury/disability that made it impossible.
5.5.4 Discriminant Analysis
Based on the discriminant analysis model developed in Chapter 4 (Section 
4.4.4) data from the psychometric response measures (tracking variance, 
tracking deviation [1-3+10-12], mean tracking deviation, mean reaction time [1- 
8], and incorrect responses), combined with age and gender were used both as 
a training dataset and a test data set in a non-parametric triweight kernel 
statistical discrimination model to discriminate between the 4 analysis groups. As 
can be seen in Table 5.8. eighty two percent of the control group were correctly 
identified as belonging to an unimpaired group (either the control group, or the 
no illegal drugs <80mg%). Sixty two percent of subjects who tested positive for 
one illegal drug were correctly identified as belonging to a drug using group 
(based solely on their psychometric test performance). Eighty two percent of the 
poly-drug users were classified as having consumed a drug (in the poly drug
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group and the illegal drug <80mg% group). One hundred percent of ACORN 
subjects who had not consumed illegal drugs were correctly identified.
Table 5.8 The ability to categorise subjects based on test performance.
Discriminant analyses of response measures based on a 
combination of the CTT and SART
Drug Group Control No drugs <80mg%
Illegal drugs 
<80mg% Poly-drug
43% 39% (11)
Control (12) 18% (5) -
No drugs <80mg% - 100% (6) - -
Illegal drugs 23% 15% (2)
<80mg% (3) 62% (8) -
Poly-drug - 18% (2) 36% (4) 45% (5)
A table detailing the results of a Discriminant analysis based on data collected in the field. Figures 
represent the percentage of subjects that were assigned to each drug group based on test 
performance, n= in parentheses
A second discriminant analysis was carried out using the same psychometric 
test variables discussed above combined with age and gender, this time with the 
addition of the FIT scores (Table 5.9). This would ascertain whether it was more 
accurate to assign a subject to a drug group using both their performance on the 
psychometric tests and their FIT result, i.e. this procedure would provide 
evidence that the combined assessment of psychomotor skills and the FIT test 
at the roadside would strengthen the likelihood of an impaired suspect being 
successfully detained. Seventy five percent of the control subjects were 
identified as belonging to a non impaired group (control group and no illegal 
drug <80mg% group) 71% of subjects who were positive for use of one illegal 
drug were correctly assigned, as were 75% of ACORN subjects who had not 
consumed any illegal drugs. One hundred percent of the poly drug users were 
correctly identified as behaving differently and uniquely to all other subjects.
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Table 5.9 The ability to categorise subjects based on test performance.
Discriminant analyses of response measures based on a 
combination of psychometric assessment and Field 
Impairment Test performance
Drug Group Control No drugs <80mg%
Illegal drugs 
<80mg% Poly-drug
Control 58% (14) 17% (4) 25% (6) -
No drugs <80mg% 
Illegal drugs
25% (1) 75% (3) ” “
<80mg% 29% (2) 71% (5) -
Poly-drug - - 38% (3) 63% (5)
A table detailing the results of a Discriminant analysis based on data collected in the field. Figures 
represent the percentage of subjects that were assigned to each drug group based on psychometric 
and FIT test performance, n= in parentheses
5.6 DISCUSSION
The assessment of psychomotor performance of a cohort of drug dependent 
users highlighted no significant performance differences between them and a 
matched control group. The discriminant analysis model that was developed 
using data obtained from recreational drug users (Chapter 4, section 4.4.4) was 
applied to this data. Based only on the subject’s performance on the CTT and 
SART the discriminant analysis was extremely successful. Twelve subjects from 
the control group were correctly identified, as well as a further 11 control 
subjects who were identified as belonging to the no drugs <80mg% group. This 
is out of a total of 28 subjects. Of the subjects who were initially grouped in the 
no drugs<80mg% group, all were correctly identified. This combines to form an 
overall correct assignment of 85% for non impaired subjects. 17 out of the 24 
subjects who had taken illegal drugs were correctly assigned in the analysis, an 
overall percentage of 71%. The results of this discriminant analysis are 
particularly encouraging and in line with published data supporting the
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hypothesis that ex drug dependent subjects will perform in a similar way to the 
general population. Schechtman and Shinar (2005) demonstrated that 
regardless of their drug using history, placebo dosed subjects performed at the 
same level. Due to the obvious ethical considerations of carrying out research 
using addictive illegal drugs it is challenging to relate the results obtained from 
this study to published literature. Only 2 studies which look at the performance 
effects of heroin users in comparison to a scientific control can be identified 
(Smith et al., 1962; Fraser et al., 1964). Although there has been data published 
relating to the poly-drug use of alcohol and illegal drugs (Mendelson et al., 1998; 
Ramaekers and Kypers, 2006; Hernandez-Lopez et al., 2002 Ramaekers et al., 
2000; Foltin et al., 1993), there is a tremendous lack of data surrounding the 
performance impairment of the poly-drug use of more than one illegal substance 
(Foltin et al., 1993).
This study also assessed the sensitivity of the Field Impairment Test. Results 
seen here are not consistent with published literature stating that the FIT is 83% 
reliable at assessing impairment in subjects (Burns and Moskowitz, 1977). In 
this study only 33% of subjects who were under the influence of illegal drugs at 
the time of testing, failed the test. The data gained here is however, in line with 
more recent published data stating that the FIT may be a redundant test when 
used in isolation to assess the impairment brought about through illegal drug use 
(Silber et al., 2005). Although on its own the FIT was not shown to be a valid 
measure of impairment, based on the fact that only 8 of the 24 subjects who 
were on drugs at the time of testing failed the test, when the results of the FIT 
were combined with the psychometric assessments a discriminant analysis 
produced extremely accurate results. A discriminant analysis of just the FIT
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scores alone would be inappropriate the subjects are already assigned to a pass 
or fail group, however, for purely exploratory reasons a combination of the FIT, 
CTT and SART data was carried out. The likelihood of identifying a drug user 
rose to above 70% (with 5 out of 7 subjects being correctly identified by the 
model), and the likelihood of identifying a poly-drug user rose to over 100% (with 
5 of the 8 poly drug users correctly assigned to that group, and the remaining 3 
assigned to the drug using <80mg% group). These are interesting results as it 
demonstrates that there is a need to further develop the use of the FIT. 
Papafotiou et al., (2005b) recommended the continuation of empirical research 
surrounding the FIT in order to develop more tests that could be used to assess 
specific elements of drug use. The results presented here suggest that 
combined assessment using both the FIT and psychometric tests would be most 
advantageous, creating a reliable method of assessing impairment at the 
roadside. However, this is problematic for two main reasons, firstly this 
combined assessment would take in excess of 30 minutes, a lengthy 
assessment if all concerned are standing in the rain on a dark roadside. 
Secondly, development of the work presented here would require that a 
standardised scoring method be developed for the FIT, one that is robust and 
has been proven to be reliable and valid. Cole and Nowaczyk (1994) stated that 
the SFST, and therefore the FIT, must be required to conform to the same 
scientific standards of reliability and validity that the scientific community would 
expect from any other form of performance assessment. Empirical validation of 
the FIT is still in its infancy, so far only one peer reviewed study has 
demonstrated a correlation between performance decrement to actual driving 
ability and performance on the SFST (Papafotiou et al., 2005b), it is therefore 
too early to conclude that the FIT is a redundant measure of impairment. It has
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clearly been demonstrated by this study that the combined use of the CTT, 
SART and FIT creates a feasible method of impairment assessment.
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CHAPTER 6
GENERAL DISCUSSION
6.1 Relevance of Findings to the Research Questions and Objective 
Assessment of Impairment at the Roadside
Driving is a multi-faceted psychomotor task, requiring an individual to respond to 
numerous conflicting stimuli simultaneously within a complex environment. This 
process is easily disrupted by the use of psychoactive substances. The 
literature analysis discussed at the beginning of this thesis highlighted the 
difficulty that exists in making firm conclusions regarding the effect illegal drugs 
have on performance, particularly performance related to driving ability. Based 
on the studies included in the analysis it was possible to conclude that each of 
the drugs discussed: cannabis, heroin, cocaine, amphetamines and ecstasy, 
had the capacity to impair either actual driving performance, or aspects of 
performance related to driving. Of particular relevance the literature analysis 
highlighted the scarcity of empirical data surrounding illegal drug use and its 
effect upon driving behaviour.
In January 2002 as a result of two European research consortia, a need was 
expressed for the development of an objective psychometric screening tool that 
could be used at the roadside to assess performance of drivers suspected of 
being impaired due to the use of an illegal drug. The hypothesis of this thesis 
was that by using a portable psychometric device it would be possible to make 
statements about an individual’s drug use retrospectively, in the absence of a 
baseline, and with just one ten minute test session. In order to test this 
hypothesis seven main research questions were identified and investigated.
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The first research question addressed which psychometric tests were the most 
appropriate for assessing performance (with particular reference to driving 
ability). The alprazolam study was carried out at the Human 
Psychopharmacology Research Unit (HPRU). As a member of the research 
team my responsibilities involved the execution of the psychometric test 
batteries, and aiding in data query resolution. I used the data from this study in 
a logistic regression and a discriminant analysis. The analysis demonstrated 
that a reaction time task, an information processing task, and a divided attention 
motor task, were particularly sensitive. The use of a discriminant analysis at this 
early stage provided important information into the possibility of being able to 
predict from a psychometric test score whether a subject was responding in the 
same manner as a normative group (a control group), or a drugged group. In 
this case it was demonstrated that it was possible to retrospectively predict 
alprazolam dosing in 72% of cases. This was taken as ample justification that it 
was possible to retrospectively predict drug use. Based on the results discussed 
in Chapter 1, a Critical Tracking Task and a Sustained Attention to Response 
task (CTT and SART) were programmed onto the portable platform to create an 
11 minute test battery. A colleague experienced in C++ programming undertook 
the software development following test specifications written by myself, and the 
research team.
The second research question required demonstration that the psychometric 
tests chosen were able to detect changes in performance produced by alcohol. 
The psychometric battery was demonstrated to be capable of distinguishing 
between the impaired performances of subjects dosed with 80mg/100ml of 
alcohol in comparison to placebo. Of particular importance Chapter 3
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demonstrated that it was possible to statistically demonstrate performance 
impairment in the absence of baseline data. It was possible to make reliable 
and robust judgments about a subject’s data when they were exposed to a 10 
minute test battery only once. This was an experiment designed by myself. I 
was responsible for authoring the protocol, obtaining ethical approval, recruiting 
the volunteers, designing the Clinical Record Forms (CRFs), conducting the 
informed consents, testing the volunteers, and collecting the data. With 
guidance from a then colleague, Dr Sigurd Johnsen I was also responsible for 
analysing the data, authoring the study report, and writing both the paper, and a 
poster for presentation at conferences. This study was limited by the fact that it 
was considerably underpowered and that a small practice effect was identified 
for the CTT. The inclusion of a pre-programmed practice session at this point in 
the project may have been beneficial, and as a result shown the device to be 
more sensitive to drug effects later in the thesis. In order to answer some of the 
uncertainty raised by the alcohol study, the recreational drug user’s investigation 
used the test battery on untrained subjects in field conditions.
The third research question addressed whether the psychometric device was 
sensitive to the effects of illegal substances. I was also responsible for this 
experiment and co-ordinated all aspects in order that it could be carried out in 
the field. I wrote the protocol, obtained ethical approval, and designed the 
Clinical Record Forms (CRFs). With the help of my colleagues and friends at 
the HPRU I recruited the volunteers, conducted the informed consents, tested 
the volunteers, and collected the data. With guidance from a then colleague, Dr 
Sigurd Johnsen I was also responsible for analysing the data, authoring the 
study report, and writing both the paper, and a poster for presentation at
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conferences. The data collected in field conditions and in the absence of any 
practice sessions, demonstrated that the test battery was sensitive to the 
impairing effects of illegal drug use, which was generally exacerbated by 
alcohol. The limitations of this study were that the study was highly 
uncontrolled, the subjects were a self selected sample and in a highly sociable 
atmosphere, quite separate from the environment at the roadside had the 
subject been stopped by the police. No account was made for the performance 
enhancing effect that being forced to prove one’s sobriety to an police officer 
may have. The literature analysis caused a necessary assumption to be made: 
use of illegal drugs will cause a measurable decrement to cognitive and/or 
psychomotor functioning. However, there is room for the argument that although 
an individual may have consumed a drug they may not be suffering from any 
measurable impairment, so any judgements about impairment and non 
impairment of the subjects in the study were quite crude, i.e. based solely on a 
positive or negative saliva analysis. There is also the converse argument that 
small amounts of stimulants may enhance subject performance in terms of faster 
reaction times.
As a consequence of the data collected in the field investigation it was possible 
to use the data to investigate the fourth research question and central 
component of this thesis. The question of whether it was possible to make 
retrospective determinations of drug use based on a one off test in the absence 
of a baseline comparator. The results presented in Chapter 4 showed that 
through use of a discriminant analysis model it was possible to retrospectively 
predict illegal drug/alcohol use in only 18% of cases. Taking into account the 
very small sizes of the drug groups the results indicate that there may be
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implications for future research, and that certainly with a bigger sample size the 
strength of the discriminant analysis model can be tested possibly leading to the 
derivation of pass or fail criteria.
The fifth research question centred on investigation of the performance of drug 
dependent subjects. This is a relevant section of the population which required 
separate investigation as although some may be experiencing quite 
considerable consequences due to combinations of illegal drug use and 
replacement therapies, they are still represented on the roads. My 
responsibilities for this study encompassed the tender application, authoring the 
protocol, obtaining ethical approval, liaising with colleagues from the drug 
rehabilitation centres, recruiting of the volunteers, designing the Clinical Record 
Forms (CRFs), conducting the informed consents, testing the volunteers, and 
collecting the data. I was also responsible for data analysis and the study 
report. The results presented in Chapter 5 demonstrated that it was not possible 
to significantly demonstrate the performance differences between a sample of 
drug dependent users and a control group. However the discriminant analysis 
was 71% accurate at identifying the drug users based on their performance.
The final research questions required investigation of the sensitivity of the Field 
Impairment Test (FIT) in isolation, and then assessment of the combined 
sensitivity of the FIT and the psychometrics tests. The FIT test when used in 
isolation was shown to be sensitive to drug effects in only 33% of cases. When 
the FIT results were combined with the psychometric data there was an 87% 
success rate at identifying those subjects that were impaired due to drug use. 
This study was limited in the fact that due to ethical considerations we were
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unable to ask subjects whether they were drivers. In combination with the drug 
tests, knowing if they were regular drivers would have provided useful 
preliminary data to justify a wider epidemiological investigation. The application 
of these results to the database of results obtained in Chapter 4 was prevented 
as the environment in which the data was collected was so disparate, as was the 
subject sample. The recreational drug users data was collected in the field in 
very sociable conditions, whereas the drug dependent users were assessed 
within the confines of a medical research centre. These very different study 
conditions prevent the combination of data at this time. The FIT section of this 
study could have been strengthened by inclusion of Horizontal or Vertical Gaze 
Nystagmus (HGN, VGN). These assessments are used in the United States as 
part of the Standardised Field Sobriety Tests (SFSTs) to determine whether a 
suspect is driving under the influence, and have been shown to be a reliable 
method of assessing alcohol impairment (Aschan, 1958; Lehti, 1976; Wilkinson 
et al., 1974; McKnight et al., 2002). However, there is conflicting data regarding 
its usefulness for assessing illegal drug use (Kosnoski et al., 1998; Adler and 
Burns, 1994). These tests involve observation of an individual’s pupil as it 
follows a moving object noting three indicators: lack of smooth pursuit; early 
angle of onset and; distinct nystagmus at extremes. At the time of planning the 
study the decision was made not to include these assessments as the intention 
was to replicate the procedure currently used by UK officers. If these additional 
assessments had been included it could have afforded a situation whereby the 
results could have been used to make statements regarding whether their 
inclusion would strengthen the sensitivity of the FIT assessment.
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Based on the data presented in this thesis it is possible to make a valid and 
reliable retrospective assessment of drug use, based on assessment of impaired 
cognitive and psychomotor performance. This was demonstrated with a test 
battery of 10 minutes duration in field conditions, in the absence of baseline data 
and with no practice sessions. The discriminant analysis presented a good case 
that the probability of predicting non drug use, and therefore non impairment, is 
high, however actually categorising those who were under the influence was 
more problematic. There are many other investigations that would need to be 
carried out to scientifically assess these issues of reliability, validity and 
sensitivity of such an impairment device.
6.2 Recommendations for Future Research
Studies that could be carried out to extend the field include:
6.2.1 The Establishment of Population Norms
A large sample of unimpaired drivers would be required to undertake the tests to 
provide the range of scores likely to be obtained in the general population. The 
establishment of performance norms is important as it will enable the creation of 
pass or fail criteria. It is expected that drugged drivers will receive scores 
outside of the normative values.
Another advantage of carrying out normative testing is that this will provide an 
opportunity to assess how the elderly experience the psychometric testing 
device. Important information regarding the practicality of the device in its 
present format would be gathered, and also whether the use of such modern 
technology would have an alienating effect to this particular population.
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6.2.2 Controlled Drug Trails
Placebo controlled crossover studies assessing the dose ranging effects of a 
number of psychoactive compounds commonly used whilst driving. These 
include for example, a hypnotic, a benzodiazepine, an antihistamine, cannabis; 
amphetamines or methamphetamines, an antidepressant, and an opioid 
analgesic. These studies would provide important data regarding performance 
differences, if any, that are present between those on prescribed medication and 
those abusing drugs.
6.2.3 Medical Conditions Trials
The impact of common diseases and medical conditions on performance of the 
portable test battery would need to be assessed. Sufferers of dementia, 
arthritis, diabetes, etc. are permitted to drive but may find the logistics of carrying 
out the test battery on the platform currently available difficult. Data gained from 
these trials will help to identify the exclusion criteria of which individuals cannot 
reasonably be expected to carry out this procedure at the roadside.
6.2.4 Reliability and Validity Testing
Large scale trials with large numbers of subjects who have recently used illegal 
substances are required. The model developed in this thesis is based on very 
small numbers of subjects. A larger subject database would provide for the 
opportunity to further test the model, allowing for the model to become stronger 
and more discriminating.
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It is also essential that there is strong evidence of a positive correlation between 
actual driving performance and test performance.
6.2.5 Police Evaluation
In order to assess the suitability and reliability of a roadside screening device an 
important evaluation stage is to include a wide scale police evaluation. Although 
the testing device may be suitable for use during field based clinical trials it may 
not meet the functional requirements necessary to make it a suitable screening 
device for officers.
6.2.6 A Large Scale Field Impairment Test Evaluation
The only sections of the FIT that have been validated as reliable tests of 
impairment are the One Leg Stand Test, and the Walk and Turn Test. The FIT 
is open to substantial criticism as the relationship between performance on the 
FIT and actual driving ability has not been shown. A full scale validation study 
would lead to further standardisation and validation of the tests. This would then 
lead to more acceptance of the tests as a viable screening tool by both the 
public and the judiciary.
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APPENDICES
Contents of Appendices
This section of the thesis contains papers I have written during my PhD course. 
Included are two papers that were written by myself, and one paper authored by 
Dr Brian Tiplady.
Appendix 1
Degia, A., Meadows, R., Johnsen S., Hindmarch, I., and Boyle, J. (2005). 
Development of a portable psychometric testing device for use in the field: an 
alcohol investigation. Perceptual and Motor Skills, 101, 383-392.
This study is detailed in Chapter 3. This was an experiment designed by myself. 
I was responsible for authoring the protocol, obtaining ethical approval, recruiting 
the volunteers, designing the Clinical Record Forms (CRFs), conducting the 
informed consents, testing the volunteers, and collecting the data. With 
guidance from a then colleague, Dr Sigurd Johnsen I was also responsible for 
analysing the data, authoring the study report, and writing both the paper, and a 
poster for presentation at the following conferences:
Drink and Drug Driving, BRAKE 2005, Westminster, London, May, 2005. 
17th International Conference on Alcohol, Drugs, and Traffic Safety, 
Glasgow, August 2004.
Traffic and Transport Psychology, Nottingham, September, 2004.
1st International Conference on Driver Behaviour and Training, Cranfield, 
November 2003.
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Appendix 2
Degia, A., Meadows R., Johnsen, S., Dixon, P., Hindmarch I., and Boyle, J.
(2006). Investigation into the suitability of a portable psychometric device to be 
used in the field: an illicit drugs field Investigation Journal of Clinical and 
Forensic Medicine, 13, 242-246
This study is detailed in Chapter 4. I was also responsible for this experiment 
and co-ordinated all aspects in order that it could be carried out in the field. I 
wrote the protocol, obtained ethical approval, and designed the Clinical Record 
Forms (CRFs). With the help of my colleagues and friends at the HPRU I 
recruited the volunteers, conducted the informed consents, tested the 
volunteers, and collected the data. With guidance from a then colleague, Dr 
Sigurd Johnsen I was also responsible for analysing the data, authoring the 
study report, and writing both the paper, and a poster for presentation at the 
following conferences:
Drink and Drug Driving, BRAKE 2005, Westminster, London, May, 2005. 
17th International Conference on Alcohol, Drugs, and Traffic Safety, 
Glasgow, August 2004.
Traffic and Transport Psychology, Nottingham, September, 2004.
1st International Conference on Driver Behaviour and Training, Cranfield, 
November 2003.
The poster from this study was awarded the ICADTS award for outstanding, 
original and sound research (2004).
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Appendix 3
Tiplady, B., Degia, A., and Dixon, P. (2005). Assessment of driver impairment: 
evaluation of a two-choice tester using ethanol. Transportation Research Part F, 
8, 299-310.
This paper cited me as a co-author as I was responsible for the execution of this 
study (as detailed in Appendix 1). I employed a cross-over design so that in 
addition to assessing the device developed for this thesis, we could also add an 
assessment arm to the study to test Dr Tiplady’s device.
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